Page last updated: 2024-10-16

choline and Glioma

choline has been researched along with Glioma in 240 studies

Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)

Research Excerpts

ExcerptRelevanceReference
"To study the association of metabolic features of F-fluorocholine in gliomas with histopathological and molecular parameters, progression-free survival (PFS) and overall survival (OS)."9.3018F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for Gliomas. ( Amo-Salas, M; Barbella, R; Borrás Moreno, JM; García Vicente, AM; Klein Zampaña, CJ; Mollejo Villanueva, M; Pena Pardo, FJ; Pérez-Beteta, J; Pérez-García, VM; Sandoval Valencia, H; Soriano Castrejón, ÁM; Villena Martín, M, 2019)
"We performed serial (1)H-MRSI examinations to assess intratumoral metabolite intensities in 16 patients receiving high-dose oral tamoxifen monotherapy for recurrent malignant glioma (WHO grade III or IV) as part of a phase II clinical trial."9.13Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma. ( Arnold, DL; Assina, R; Caramanos, Z; Langleben, A; Leblanc, R; Preul, MC; Sankar, T; Villemure, JG, 2008)
"This meta-analysis indicated 11C-choline has high diagnostic accuracy for the identification of tumor relapse from radiation induced necrosis in gliomas."8.98Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis: A systematic review and meta-analysis. ( Chen, G; Gao, L; Li, T; Xu, W; Zheng, J, 2018)
"Twenty-six patients (mean age 16 years, range 8-22 years) with suspected glioma disease progression were evaluated with 18 F-choline PET/MRI."8.31Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults. ( Al-Khayfawee, A; Bomanji, J; Cockle, JV; Ferrazzoli, V; Fraioli, F; Hyare, H; Shankar, A; Tang, C, 2023)
"The aim of this study was to assess the prognostic performance of postoperative 18F-fluorocholine PET/CT in patients with high-grade glioma (HGG)."8.12Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria. ( Amo-Salas, M; García Vicente, AM; López Menéndez, C; Pena Pardo, FJ; Pérez-Beteta, J; Soriano Castrejón, ÁM; Villena Martín, M, 2022)
"Patients with a previous gross total resection of glioma and the first suspicious or doubtful for recurrence MRI were prospectively included and subjected to 18 F-fluorocholine PET/CT."8.12Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study. ( Amo-Salas, M; García Vicente, AM; Lozano Setien, E; Sandoval Valencia, H; Soriano Castrejón, ÁM, 2022)
"To investigate the diagnostic accuracy of O-(2-[18F]-fluoroethyl)-L-tyrosine (18F-FET) and fluoromethyl-(18F)-dimethyl-2-hydroxyethyl-ammonium chloride (18F-FCH) computed tomography (CT) in patients with primary low-grade gliomas (LGG)."8.0218F-FET and 18F-choline PET-CT in patients with MRI-suspected low-grade gliomas: a pilot study. ( Baučić, M; Golubić, AT; Hodolič, M; Huić, D; Mišir Krpan, A; Mrak, G; Nemir, J; Žuvić, M, 2021)
"Ischemic complications after resection of high-grade glioma are frequent and may constitute potential cause of false-positive results in postsurgical evaluation using F-fluorocholine PET/CT."7.91Ischemic Complications After High-Grade Glioma Resection Could Interfere With Residual Tumor Detection With 18F-Fluorocholine PET/CT. ( García Vicente, AM; Martinez Madrigal, MM; Pena Pardo, FJ; Rodriguez Muñoz, MJ; Soriano Castrejón, A, 2019)
"The aim of this study is to assess the different metabolic activities characteristic of glioma recurrence and radiation necrosis (RN) and to explore the diagnostic accuracy for differentiation of the two conditions using (11)C-methionine (MET), (11)C-choline (CHO), and (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)."7.80Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis. ( Asano, Y; Iwama, T; Miwa, K; Nomura, Y; Shinoda, J; Takenaka, S; Yano, H; Yonezawa, S, 2014)
"The aim of the present study is to evaluate the role of (11)C-choline positron emission tomography/computed tomography (PET/CT) in detecting tumor recurrence and predicting survival in post-treatment patients with high-grade gliomas."7.80(11)C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas. ( Hu, X; Li, W; Ma, L; Sun, J; Wang, S; Wang, X, 2014)
"To study choline metabolism in biopsies from nonenhancing Grade 2 (AS2) and Grade 3 (AS3) astrocytomas to determine whether (1) phosphocholine (PC) dominates in AS3, and (2) PC is associated with proliferation or angiogenesis."7.77Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. ( Berger, MS; Chang, SM; Chiu, KS; Chu, PW; Cloyd, CP; McKnight, TR; Phillips, JJ; Smith, KJ, 2011)
"This study was designed to evaluate proton magnetic resonance spectroscopy ((1)H-MRS) for monitoring the WHO grade II glioma (low-grade glioma (LGG)) treated with temozolomide (TMZ)."7.77Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy. ( Abud, L; Capelle, L; Chiras, J; Costalat, R; De Marco, G; Guillevin, R; Habas, C; Hoang-Xuan, K; Menuel, C; Taillibert, S; Vallée, JN, 2011)
"The present study was done for evaluation of the possible influence of the oral administration of choline on metabolic characteristics of gliomas detected with proton magnetic resonance spectroscopy ((1)H-MRS)."7.75Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel (1)H-MRS at 1.5 T. ( Chernov, MF; Hori, T; Iseki, H; Kubo, O; Maruyama, T; Muragaki, Y; Nakamura, R; Ono, Y; Takakura, K; Usukura, M; Yoshida, S, 2009)
"PURPOSE Our purpose was to evaluate cerebral glioma grade by using normal side creatine (Cr) as an internal reference in multi-voxel 1H-MR spectroscopy."7.74Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy. ( Ağildere, AM; Atalay, B; Elhan, AH; Geyik, E; Ozen, O; Yerli, H, 2007)
" The aim of this study was to determine uptake of the (18)F-labeled PET tracers (18)F-fluorocholine (N,N-dimethyl-N-(18)F-fluoromethyl-2-hydroxyethylammonium), (18)F-fluoro-ethyl-l-tyrosine (FET), and (18)F-FDG in C6 gliomas of the rat and to correlate it with uptake of the anti-extra domain B antibody (131)I-SIP(L19) as a marker of neoangiogenesis."7.74Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis. ( Alessi, P; Biollaz, G; Buck, A; Neri, D; Pahnke, J; Spaeth, N; Trachsel, E; Treyer, V; Weber, B; Wyss, MT, 2007)
"Diffusion tensor imaging and multiple voxel magnetic resonance spectroscopy were performed in the MRI follow-up of a patient with a glioma treated with temozolomide chemotherapy."7.74Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy. ( Enting, RH; Heesters, MA; Irwan, R; Meiners, LC; Oudkerk, M; Potze, JH; Sijens, PE; van der Graaf, WT, 2007)
"9L glioma cells were incubated with [(18)F]FCH and [(14)C]choline under normoxic and hypoxic (1% O(2)) conditions and analyzed for metabolic fate."7.74Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats. ( Bansal, A; Degrado, TR; Hara, T; Harris, RA; Shuyan, W, 2008)
"To examine the relationship between apparent diffusion coefficients (ADC) from diffusion weighted imaging (DWI) and choline levels from proton magnetic resonance spectroscopic imaging (MRSI) in newly diagnosed Grade II and IV gliomas within distinct anatomic regions."7.74Relationship between choline and apparent diffusion coefficient in patients with gliomas. ( Cha, S; Chang, SM; Crawford, FW; Khayal, IS; Lamborn, KR; McKnight, TR; Nelson, SJ; Saraswathy, S, 2008)
" The aim of this study was to assess the metabolic activity of gliomas using (11)C-methionine (MET), [(18)F] fluorodeoxyglucose (FDG), and (11)C-choline (CHO) PET and to explore the correlation between the metabolic activity and histopathologic features."7.74Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. ( Iwama, T; Kato, T; Maruyama, T; Miwa, K; Muragaki, Y; Nakayama, N; Okumura, A; Shinoda, J; Yano, H; Yoshimura, S, 2008)
"The purpose of this study was to determine the predictive value of [18F]fluoroethyl-L-tyrosine (FET)-positron emission tomography (PET) and magnetic resonance (MR) spectroscopy for tumor diagnosis in patients with suspected gliomas."7.73Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. ( Coenen, H; Floeth, FW; Hamacher, K; Langen, KJ; Messing-Jünger, M; Müller, HW; Pauleit, D; Reifenberger, G; Sabel, M; Steiger, HJ; Stummer, W; Weber, F; Wittsack, HJ; Woebker, G; Zilles, K, 2005)
"The concentrations of endogenous amino acids and choline in the extracellular fluid of human cerebral gliomas have been measured, for the first time, by in vivo microdialysis."7.72Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study. ( Ballini, C; Bianchi, L; Bricolo, A; De Micheli, E; Della Corte, L; Fattori, M; Pedata, F; Tipton, KF; Venturi, C, 2004)
" The purpose of this study was to investigate the correlation between the semiquantitative choline-containing compound level (Cho value) measured by MR spectroscopy and the Ki-67 labeling index in gliomas."7.70Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. ( Kumabe, T; Shimizu, H; Shirane, R; Yoshimoto, T, 2000)
" Here we show that the phorbol ester-stimulated release of choline- and ethanolamine-metabolites from C6 glioma cells due to phospholipid hydrolysis by phospholipase D (PLD) is not inhibited by rapamycin or PD98059, specific inhibitors respectively of p70 S6 kinase and MAPKK (MEK) and thus of MAPKAP kinase-1beta but is still completely blocked by Ro31-8220."7.69Ro31-8220 inhibits protein kinase C to block the phorbol ester-stimulated release of choline- and ethanolamine-metabolites from C6 glioma cells: p70 S6 kinase and MAPKAP kinase-1beta do not function downstream of PKC in activating PLD. ( Beale, G; Mallon, B; Morreale, A; Rumsby, M; Watson, J, 1997)
"Palytoxin-induced whole-cell and single channel currents were recorded in mouse neuroblastoma cells."7.68Characterization of palytoxin-induced channels in mouse neuroblastoma cells. ( Dubois, JM; Rouzaire-Dubois, B, 1990)
"We have examined the effects of phorbol esters on phosphatidylcholine (PtdCho) metabolism in the neuroblastoma-glioma hybrid cell line NG108-15."7.67Phosphatidylcholine biosynthesis in the neuroblastoma-glioma hybrid cell line NG108-15: stimulation by phorbol esters. ( Blusztajn, JK; Freese, A; Liscovitch, M; Wurtman, RJ, 1986)
"The neuroblastoma x glioma hybrid clone NG108-15 is able to release acetylcholine upon depolarization and form cholinergic neuromuscular synapses in culture."7.66Choline uptake by the neuroblastoma x glioma hybrid, NG108-15. ( McGee, R, 1980)
"Human glioma cells (138MG) have a low-affinity uptake system for choline (Km = 20 microM; Vmax = 56 pmol/min/10(6) cells)."7.66Uptake and release of choline in cultures of human glioma cells. ( Walum, E, 1981)
"Gliomas are characterized by an inherent diffuse and irregular morphology that prevents defining a boundary between tumor and healthy tissue, both in imaging assessment and surgical field."5.72Multiple and Diffuse Gliomas by 18F-Fluorocholine PET/CT: Two Sides of the Same Coin. ( Bosque, JJ; García Vicente, AM; Pérez-Beteta, J; Pérez-García, VM; Soriano Castrejón, ÁM, 2022)
"Gliomas are characterized by intratumoral histological heterogeneity, coexisting foci of low and high grade."5.56Low-Grade Versus High-Grade Glioma… That Is the Question. 18F-Fluorocholine PET in the Detection of Anaplastic Focus. ( Borrás Moreno, JM; Cordero García, JM; García Vicente, AM; López Menéndez, C; Soriano Castrejón, A, 2020)
"High-grade glioma is a very aggressive and infiltrative tumor in which complete resection is a chance for a better outcome."5.4618F-Fluorocholine PET/CT, Brain MRI, and 5-Aminolevulinic Acid for the Assessment of Tumor Resection in High-Grade Glioma. ( Borrás Moreno, JM; García Vicente, AM; Jiménez Aragón, F; Jiménez Londoño, GA; Villena Martín, M, 2017)
"The follow-up of treated low-grade glioma (LGG) requires the evaluation of subtle clinical changes and MRI results."5.42¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility. ( Chamorro Santos, CE; Gómez-Río, M; Lardelli-Claret, P; Llamas-Elvira, JM; Luque Caro, R; Olivares Granados, G; Rodríguez-Fernández, A; Santiago Chinchilla, A; Testart Dardel, N; Zurita Herrera, M, 2015)
"Choline is an essential nutrient necessary for synthesis of membrane phospholipids, cell signalling molecules and acetylcholine."5.35Detection of choline transporter-like 1 protein CTL1 in neuroblastoma x glioma cells and in the CNS, and its role in choline uptake. ( Dolezal, V; Dove, R; Lisá, V; Machová, E; Meunier, FM; Newcombe, J; O'Regan, S; Prentice, J, 2009)
"F98 gliomas were induced in 26 rats."5.33Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat. ( Biollaz, G; Buck, A; Goepfert, K; Lutz, A; Pahnke, J; Spaeth, N; Treyer, V; Weber, B; Westera, G; Wyss, MT, 2006)
"To study the association of metabolic features of F-fluorocholine in gliomas with histopathological and molecular parameters, progression-free survival (PFS) and overall survival (OS)."5.3018F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for Gliomas. ( Amo-Salas, M; Barbella, R; Borrás Moreno, JM; García Vicente, AM; Klein Zampaña, CJ; Mollejo Villanueva, M; Pena Pardo, FJ; Pérez-Beteta, J; Pérez-García, VM; Sandoval Valencia, H; Soriano Castrejón, ÁM; Villena Martín, M, 2019)
"Pediatric brain gliomas are not always amenable for complete surgical excision, therefore adjuvant treatment for a large tumor mass is often required."5.30Variation of post-treatment H-MRSI choline intensity in pediatric gliomas. ( Alger, J; Gupta, RK; Lazareff, JA, 1999)
"We explored the clinical values of (11)C-choline ((11)C-CHO) PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas."5.1611C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas. ( Chang, SM; Fang, HH; Jia, HW; Li, FM; Liang, YK; Nie, Q; Wang, RM; Yang, P; Zhang, J; Zhao, WR; Zhu, Q, 2012)
"We performed serial (1)H-MRSI examinations to assess intratumoral metabolite intensities in 16 patients receiving high-dose oral tamoxifen monotherapy for recurrent malignant glioma (WHO grade III or IV) as part of a phase II clinical trial."5.13Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma. ( Arnold, DL; Assina, R; Caramanos, Z; Langleben, A; Leblanc, R; Preul, MC; Sankar, T; Villemure, JG, 2008)
"This meta-analysis indicated 11C-choline has high diagnostic accuracy for the identification of tumor relapse from radiation induced necrosis in gliomas."4.98Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis: A systematic review and meta-analysis. ( Chen, G; Gao, L; Li, T; Xu, W; Zheng, J, 2018)
" There are a number of metabolites that can be identified by standard brain proton MRS but only a few of them has a clinical significance in diagnosis of gliomas including N-acetylaspartate, choline, creatine, myo-inositol, lactate, and lipids."4.89Potential of MR spectroscopy for assessment of glioma grading. ( Bulik, M; Jancalek, R; Mechl, M; Skoch, A; Vanicek, J, 2013)
"Twenty-six patients (mean age 16 years, range 8-22 years) with suspected glioma disease progression were evaluated with 18 F-choline PET/MRI."4.31Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults. ( Al-Khayfawee, A; Bomanji, J; Cockle, JV; Ferrazzoli, V; Fraioli, F; Hyare, H; Shankar, A; Tang, C, 2023)
"The aim of this study was to assess the prognostic performance of postoperative 18F-fluorocholine PET/CT in patients with high-grade glioma (HGG)."4.12Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria. ( Amo-Salas, M; García Vicente, AM; López Menéndez, C; Pena Pardo, FJ; Pérez-Beteta, J; Soriano Castrejón, ÁM; Villena Martín, M, 2022)
"Patients with a previous gross total resection of glioma and the first suspicious or doubtful for recurrence MRI were prospectively included and subjected to 18 F-fluorocholine PET/CT."4.12Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study. ( Amo-Salas, M; García Vicente, AM; Lozano Setien, E; Sandoval Valencia, H; Soriano Castrejón, ÁM, 2022)
"To investigate the diagnostic accuracy of O-(2-[18F]-fluoroethyl)-L-tyrosine (18F-FET) and fluoromethyl-(18F)-dimethyl-2-hydroxyethyl-ammonium chloride (18F-FCH) computed tomography (CT) in patients with primary low-grade gliomas (LGG)."4.0218F-FET and 18F-choline PET-CT in patients with MRI-suspected low-grade gliomas: a pilot study. ( Baučić, M; Golubić, AT; Hodolič, M; Huić, D; Mišir Krpan, A; Mrak, G; Nemir, J; Žuvić, M, 2021)
"The aim of this study was to investigate the quantitative 18F-fluoroethylcholine (CHO) PET characteristics for differentiating lower-grade glioma (LGG) from glioblastoma (GBM)."4.02Quantitative Features From CHO PET Distinguish the WHO Grades of Primary Diffuse Glioma. ( Chen, W; Cheng, X; Jiang, C; Kong, Z; Liu, D; Ma, W; Wang, Y, 2021)
" These methods were evaluated for segmentation of volumetric MRSI studies of gliomas using maps of the choline to N-acetylaspartate ratio, and a qualitative comparison of lesion volumes carried out."3.91Lesion segmentation for MR spectroscopic imaging using the convolution difference method. ( Maudsley, AA, 2019)
"Ischemic complications after resection of high-grade glioma are frequent and may constitute potential cause of false-positive results in postsurgical evaluation using F-fluorocholine PET/CT."3.91Ischemic Complications After High-Grade Glioma Resection Could Interfere With Residual Tumor Detection With 18F-Fluorocholine PET/CT. ( García Vicente, AM; Martinez Madrigal, MM; Pena Pardo, FJ; Rodriguez Muñoz, MJ; Soriano Castrejón, A, 2019)
"Age and choline/creatine ratio are strong independent prognostic factors in high grade gliomas."3.81Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas. ( Kelekis, N; Kokakis, I; Kouloulias, V; Kouvaris, JR; Kyrgias, G; Mosa, E; Papathanasiou, M; Pissakas, G; Pistevou-Gombaki, K; Tolia, M; Tsoukalas, N; Verganelakis, D, 2015)
"The aim of this study is to assess the different metabolic activities characteristic of glioma recurrence and radiation necrosis (RN) and to explore the diagnostic accuracy for differentiation of the two conditions using (11)C-methionine (MET), (11)C-choline (CHO), and (18)F-fluorodeoxyglucose (FDG)-positron emission tomography (PET)."3.80Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis. ( Asano, Y; Iwama, T; Miwa, K; Nomura, Y; Shinoda, J; Takenaka, S; Yano, H; Yonezawa, S, 2014)
"The aim of the present study is to evaluate the role of (11)C-choline positron emission tomography/computed tomography (PET/CT) in detecting tumor recurrence and predicting survival in post-treatment patients with high-grade gliomas."3.80(11)C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas. ( Hu, X; Li, W; Ma, L; Sun, J; Wang, S; Wang, X, 2014)
"There is significant elevation of the choline (Cho) /creatine (Cr) ratio, Cho peak and depression of the N-acetylaspartate (NAA) peak in gliomas."3.78Preoperative assessment using multimodal functional magnetic resonance imaging techniques in patients with brain gliomas. ( Shang, HB; Zhang, WF; Zhao, WG, 2012)
" The aim of this work is to evaluate whether regional cerebral blood volume (rCBV), as well as choline (Cho), N-acetyl-aspartate (NAA) and myo-inositol (mIns) concentrations differ between tumefactive lesions and World Health Organization (WHO) grade II-III gliomas."3.77Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas. ( Blasel, S; Hattingen, E; Jansen, V; Mueller, K; Pfeilschifter, W; Zanella, F, 2011)
"To study choline metabolism in biopsies from nonenhancing Grade 2 (AS2) and Grade 3 (AS3) astrocytomas to determine whether (1) phosphocholine (PC) dominates in AS3, and (2) PC is associated with proliferation or angiogenesis."3.77Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma. ( Berger, MS; Chang, SM; Chiu, KS; Chu, PW; Cloyd, CP; McKnight, TR; Phillips, JJ; Smith, KJ, 2011)
"This study was designed to evaluate proton magnetic resonance spectroscopy ((1)H-MRS) for monitoring the WHO grade II glioma (low-grade glioma (LGG)) treated with temozolomide (TMZ)."3.77Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy. ( Abud, L; Capelle, L; Chiras, J; Costalat, R; De Marco, G; Guillevin, R; Habas, C; Hoang-Xuan, K; Menuel, C; Taillibert, S; Vallée, JN, 2011)
"Our purpose was to investigate whether in vivo proton magnetic resonance spectroscopic imaging, using normalized concentrations of total choline (tCho) and total creatine (tCr), can differentiate between WHO grade I pilocytic astrocytoma (PA) and diffuse, fibrillary WHO grade II astrocytoma (DA) in children."3.76Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas. ( Franz, K; Hattingen, E; Kieslich, M; Lehrbecher, T; Pilatus, U; Porto, L, 2010)
"The present study was done for evaluation of the possible influence of the oral administration of choline on metabolic characteristics of gliomas detected with proton magnetic resonance spectroscopy ((1)H-MRS)."3.75Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel (1)H-MRS at 1.5 T. ( Chernov, MF; Hori, T; Iseki, H; Kubo, O; Maruyama, T; Muragaki, Y; Nakamura, R; Ono, Y; Takakura, K; Usukura, M; Yoshida, S, 2009)
"PURPOSE Our purpose was to evaluate cerebral glioma grade by using normal side creatine (Cr) as an internal reference in multi-voxel 1H-MR spectroscopy."3.74Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy. ( Ağildere, AM; Atalay, B; Elhan, AH; Geyik, E; Ozen, O; Yerli, H, 2007)
" The aim of this study was to determine uptake of the (18)F-labeled PET tracers (18)F-fluorocholine (N,N-dimethyl-N-(18)F-fluoromethyl-2-hydroxyethylammonium), (18)F-fluoro-ethyl-l-tyrosine (FET), and (18)F-FDG in C6 gliomas of the rat and to correlate it with uptake of the anti-extra domain B antibody (131)I-SIP(L19) as a marker of neoangiogenesis."3.74Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis. ( Alessi, P; Biollaz, G; Buck, A; Neri, D; Pahnke, J; Spaeth, N; Trachsel, E; Treyer, V; Weber, B; Wyss, MT, 2007)
"Diffusion tensor imaging and multiple voxel magnetic resonance spectroscopy were performed in the MRI follow-up of a patient with a glioma treated with temozolomide chemotherapy."3.74Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy. ( Enting, RH; Heesters, MA; Irwan, R; Meiners, LC; Oudkerk, M; Potze, JH; Sijens, PE; van der Graaf, WT, 2007)
"9L glioma cells were incubated with [(18)F]FCH and [(14)C]choline under normoxic and hypoxic (1% O(2)) conditions and analyzed for metabolic fate."3.74Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats. ( Bansal, A; Degrado, TR; Hara, T; Harris, RA; Shuyan, W, 2008)
"To examine the relationship between apparent diffusion coefficients (ADC) from diffusion weighted imaging (DWI) and choline levels from proton magnetic resonance spectroscopic imaging (MRSI) in newly diagnosed Grade II and IV gliomas within distinct anatomic regions."3.74Relationship between choline and apparent diffusion coefficient in patients with gliomas. ( Cha, S; Chang, SM; Crawford, FW; Khayal, IS; Lamborn, KR; McKnight, TR; Nelson, SJ; Saraswathy, S, 2008)
" The aim of this study was to assess the metabolic activity of gliomas using (11)C-methionine (MET), [(18)F] fluorodeoxyglucose (FDG), and (11)C-choline (CHO) PET and to explore the correlation between the metabolic activity and histopathologic features."3.74Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. ( Iwama, T; Kato, T; Maruyama, T; Miwa, K; Muragaki, Y; Nakayama, N; Okumura, A; Shinoda, J; Yano, H; Yoshimura, S, 2008)
"The purpose of this study was to determine the predictive value of [18F]fluoroethyl-L-tyrosine (FET)-positron emission tomography (PET) and magnetic resonance (MR) spectroscopy for tumor diagnosis in patients with suspected gliomas."3.73Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy. ( Coenen, H; Floeth, FW; Hamacher, K; Langen, KJ; Messing-Jünger, M; Müller, HW; Pauleit, D; Reifenberger, G; Sabel, M; Steiger, HJ; Stummer, W; Weber, F; Wittsack, HJ; Woebker, G; Zilles, K, 2005)
"In vivo magnetic resonance spectroscopy (MRS) studies of glial brain tumours reported that higher grade of astrocytoma is associated with increased level of choline-containing compounds (Cho) and decreased levels of N-acetylaspartate (NAA) and creatine and phosphocreatine (Cr)."3.73In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy. ( Belan, V; Béres, A; De Riggo, J; Dobrota, D; Galanda, M; Likavcanová, K; Liptaj, T; Mlynárik, V; Prónayová, N, 2005)
"Diffusion tensor imaging (DTI) and MR spectroscopy are noninvasive, quantitative tools for the preoperative assessment of gliomas with which the quantitative parameter fractional anisotropy (FA) and the concentration of neurometabolites N-acetylaspartate (NAA), choline (Cho), creatine (Cr) of the brain can be determined."3.73Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients--a combined diffusion tensor imaging and 1H-MR spectroscopy study. ( Ding, XQ; Fiehler, J; Goebell, E; Hagel, C; Heese, O; Kucinski, T; Nietz, S; Paustenbach, S; Westphal, M; Zeumer, H, 2006)
"The concentrations of endogenous amino acids and choline in the extracellular fluid of human cerebral gliomas have been measured, for the first time, by in vivo microdialysis."3.72Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study. ( Ballini, C; Bianchi, L; Bricolo, A; De Micheli, E; Della Corte, L; Fattori, M; Pedata, F; Tipton, KF; Venturi, C, 2004)
" The concentration of taurine (Tau) in medulloblastomas was 29."3.72In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. ( Harada, K; Houkin, K; Tong, Z; Yamaki, T, 2004)
" The concentration of taurine (Tau) in medulloblastomas was 29."3.72In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard. ( Harada, K; Houkin, K; Tong, Z; Yamaki, T, 2004)
"Data obtained preoperatively from three-dimensional (3D)/proton magnetic resonance (MR) spectroscopy were compared with the results of histopathological assays of tissue biopsies obtained during surgery to verify the sensitivity and specificity of a choline-containing compound-N-acetylaspartate index (CNI) used to distinguish tumor from nontumorous tissue within T2-hyperintense and contrast-enhancing lesions of patients with untreated gliomas."3.71Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence. ( Berger, MS; Dillon, WP; Graves, EE; Lu, Y; McDermott, MW; McKnight, TR; Nelson, SJ; Pirzkall, A; Vigneron, DB; von dem Bussche, MH, 2002)
" MRS of normal brain parenchyma displays 4 main metabolites: N-acetyl aspartate (neuronal marker), creatine (cellular density marker), choline (membrane activity marker) and myoinositol (glial marker); pathological processes lead to variations of the level of these metabolites and/or the appearance of abnormal metabolites (lactate), following different patterns according to pathological process involved: glioma, meningioma, metastasis, bacterial or toxoplasmic abscess, radionecrosis."3.71[Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors]. ( Confort-Gouny, S; Cozzone, PJ; Dufour, H; Galanaud, D; Le Fur, Y; Nicoli, F; Peragut, JC; Ranjeva, JP; Roche, P; Viout, P, 2002)
" Non-neoplastic lesions such as cerebral infarctions and brain abscesses are marked by decreases in choline (Cho), creatine (Cr) and N-acetyl-aspartate (NAA), while tumours generally have elevated Cho and decreased levels of Cr and NAA."3.71Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. ( Herminghaus, S; Krings, T; Lanfermann, H; Marquardt, G; Möller-Hartmann, W; Pilatus, U; Zanella, FE, 2002)
"The authors sought to compare 1H magnetic resonance spectroscopy (MRS) spectra from extracts of low-grade and high-grade gliomas, especially with respect to the signals of choline-containing compounds."3.70Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors. ( Berry, I; Breil, S; Delisle, MB; Gilard, V; Malet-Martino, M; Manelfe, C; Ranjeva, JP; Sabatier, J; Terral, C; Tremoulet, M, 1999)
" The purpose of this study was to investigate the correlation between the semiquantitative choline-containing compound level (Cho value) measured by MR spectroscopy and the Ki-67 labeling index in gliomas."3.70Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas. ( Kumabe, T; Shimizu, H; Shirane, R; Yoshimoto, T, 2000)
" All high-grade gliomas (n = 37) showed high choline and low or absent N-acetyl-L-aspartate and creatine along with lipid and/or lactate, whereas low-grade gliomas (n = 23) were characterized by low N-acetyl-aspartate and creatine and high choline and presence of only lactate."3.69Characterization of intracranial mass lesions with in vivo proton MR spectroscopy. ( Chhabra, DK; Gupta, RK; Jain, VK; Pandey, R; Poptani, H; Roy, R, 1995)
" The NAA (N-acetylaspartate)/Cho (choline) ratio of Grade 2 astrocytoma was higher than that of Grade 4."3.69Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy. ( Bandou, K; Harada, M; Kannuki, S; Miyoshi, H; Nishitani, H; Tanouchi, M, 1995)
"(a) Hamartomas showed higher N-acetyl aspartate/creatine, creatine/choline, and N-acetyl aspartate/choline ratios than gliomas."3.69Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation. ( Castillo, M; Green, C; Greenwood, R; Kwock, L; Schiro, S; Smith, K; Wilson, D, 1995)
" We used proton nuclear magnetic resonance spectroscopy to detect the presence of simple metabolites (such as lactic acid, creatine/phosphocreatine, N-acetyl aspartate, and the "choline" pool) in extracts of a human glioma grown subcutaneously in athymic ("nu/nu") mice."3.69Effects of therapy on the 1H NMR spectrum of a human glioma line. ( Cazzaniga, S; Charles, HC; Schold, SC; Sostman, HD, 1994)
"A rat glioma cell line (C6) was incubated with C-14 choline; the time course of uptake and metabolism was determined in vitro."3.69Brain tumors: detection with C-11 choline PET. ( Fujii, K; Haisa, T; Hara, T; Kondo, T; Kosaka, N; Mitsui, I; Nishijima, M; Shinoura, N; Yamamoto, H, 1997)
" In this study, we describe the effect of ethanol on the incorporation of radioactive serine, choline and ethanolamine into their respective phospholipids in a neuroblastoma x glioma hybrid cell line (NG 108-15)."3.69Ethanol potentiates the uptake of [14C]serine into phosphatidylserine by base-exchange reaction in NG 108-15 cells. ( Alling, C; Gustavsson, L; Rodríguez, FD, 1996)
" Here we show that the phorbol ester-stimulated release of choline- and ethanolamine-metabolites from C6 glioma cells due to phospholipid hydrolysis by phospholipase D (PLD) is not inhibited by rapamycin or PD98059, specific inhibitors respectively of p70 S6 kinase and MAPKK (MEK) and thus of MAPKAP kinase-1beta but is still completely blocked by Ro31-8220."3.69Ro31-8220 inhibits protein kinase C to block the phorbol ester-stimulated release of choline- and ethanolamine-metabolites from C6 glioma cells: p70 S6 kinase and MAPKAP kinase-1beta do not function downstream of PKC in activating PLD. ( Beale, G; Mallon, B; Morreale, A; Rumsby, M; Watson, J, 1997)
" Oligodendrogliomas had higher choline levels than astrocytomas."3.68[1H magnetic resonance spectroscopy in intracranial tumors and cerebral ischemia]. ( Felber, SR, 1993)
"Palytoxin-induced whole-cell and single channel currents were recorded in mouse neuroblastoma cells."3.68Characterization of palytoxin-induced channels in mouse neuroblastoma cells. ( Dubois, JM; Rouzaire-Dubois, B, 1990)
"Differences between the influences of phorbol esters (such as 4 beta-12-O-tetradecanoylphorbol 13-acetate) and of fatty acids (such as oleic acid) on the synthesis and turnover of phosphatidylcholine (PtdCho) and other phospholipids have been studied in glioma (C6), neuroblastoma (N1E-115), and hybrid (NG108-15) cells in culture using [methyl-3H]choline, [32P]Pi, [1,2-14C]ethanolamine, or 1-14C-labeled fatty acids as lipid precursors."3.67Alterations of phospholipid metabolism by phorbol esters and fatty acids occur by different intracellular mechanisms in cultured glioma, neuroblastoma, and hybrid cells. ( Byers, DM; Cook, HW; Palmer, FB; Spence, MW, 1989)
"We have examined the effects of phorbol esters on phosphatidylcholine (PtdCho) metabolism in the neuroblastoma-glioma hybrid cell line NG108-15."3.67Phosphatidylcholine biosynthesis in the neuroblastoma-glioma hybrid cell line NG108-15: stimulation by phorbol esters. ( Blusztajn, JK; Freese, A; Liscovitch, M; Wurtman, RJ, 1986)
"The neuroblastoma x glioma hybrid clone NG108-15 is able to release acetylcholine upon depolarization and form cholinergic neuromuscular synapses in culture."3.66Choline uptake by the neuroblastoma x glioma hybrid, NG108-15. ( McGee, R, 1980)
"Human glioma cells (138MG) have a low-affinity uptake system for choline (Km = 20 microM; Vmax = 56 pmol/min/10(6) cells)."3.66Uptake and release of choline in cultures of human glioma cells. ( Walum, E, 1981)
"Malignant brain tumors are one of the most lethal cancers."2.53The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors. ( Castro, MG; Lowenstein, PR, 2016)
"11C-choline has been reported as a suitable tracer for neuroimaging application."2.52Clinical applications of choline PET/CT in brain tumors. ( Ciarmiello, A; Gaeta, MC; Giovannini, E; Lazzeri, P; Milano, A, 2015)
"Gliomas are characterized by an inherent diffuse and irregular morphology that prevents defining a boundary between tumor and healthy tissue, both in imaging assessment and surgical field."1.72Multiple and Diffuse Gliomas by 18F-Fluorocholine PET/CT: Two Sides of the Same Coin. ( Bosque, JJ; García Vicente, AM; Pérez-Beteta, J; Pérez-García, VM; Soriano Castrejón, ÁM, 2022)
"Chordoid gliomas are extremely rare entities, which are generally considered occurring exclusively in the third ventricle."1.56Chordoid glioma: an entity occurring not exclusively in the third ventricle. ( Du, J; Fang, J; Li, G; Wang, S; Xu, Y; Yang, B; Yang, C, 2020)
"Gliomas are characterized by intratumoral histological heterogeneity, coexisting foci of low and high grade."1.56Low-Grade Versus High-Grade Glioma… That Is the Question. 18F-Fluorocholine PET in the Detection of Anaplastic Focus. ( Borrás Moreno, JM; Cordero García, JM; García Vicente, AM; López Menéndez, C; Soriano Castrejón, A, 2020)
"High-grade glioma is a very aggressive and infiltrative tumor in which complete resection is a chance for a better outcome."1.4618F-Fluorocholine PET/CT, Brain MRI, and 5-Aminolevulinic Acid for the Assessment of Tumor Resection in High-Grade Glioma. ( Borrás Moreno, JM; García Vicente, AM; Jiménez Aragón, F; Jiménez Londoño, GA; Villena Martín, M, 2017)
"Glioma is one of the most common types of brain tumors."1.46Assessment of alterations in X-ray irradiation-induced DNA damage of glioma cells by using proton nuclear magnetic resonance spectroscopy. ( Li, F; Li, H; Shi, W; Xu, Y; Yi, C; Zeng, Q, 2017)
"Glioma is the most common type of the primary CNS tumor."1.43Noninvasive evaluation of radiation-enhanced glioma cells invasiveness by ultra-high-field (1)H-MRS in vitro. ( Cui, Y; Li, FY; Li, HX; Shi, WQ; Wang, JZ; Xu, YJ; Zeng, QS, 2016)
"The follow-up of treated low-grade glioma (LGG) requires the evaluation of subtle clinical changes and MRI results."1.42¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility. ( Chamorro Santos, CE; Gómez-Río, M; Lardelli-Claret, P; Llamas-Elvira, JM; Luque Caro, R; Olivares Granados, G; Rodríguez-Fernández, A; Santiago Chinchilla, A; Testart Dardel, N; Zurita Herrera, M, 2015)
"Primary brain tumors (PBT), in particular gliomas, are among the most difficult neoplasms to treat, necessitating good quality imaging to guide clinicians at many junctures."1.37Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience. ( Lam, WW; Ng, DC; Ong, SC; See, SJ; Wong, WY; Yu, SW, 2011)
"Monofocal acute inflammatory demyelination (MAID), which is observable by CT and MRI as a well-enhanced mass lesion with prominent perifocal edema, is very similar to malignant gliomas radiologically, making differential diagnosis of the two pathologies difficult."1.37Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET. ( Aki, T; Asano, Y; Ito, T; Iwama, T; Miwa, K; Shinoda, J; Takenaka, S; Yokoyama, K, 2011)
"Choline is an essential nutrient necessary for synthesis of membrane phospholipids, cell signalling molecules and acetylcholine."1.35Detection of choline transporter-like 1 protein CTL1 in neuroblastoma x glioma cells and in the CNS, and its role in choline uptake. ( Dolezal, V; Dove, R; Lisá, V; Machová, E; Meunier, FM; Newcombe, J; O'Regan, S; Prentice, J, 2009)
"Using discriminant analysis, this study found that MR spectroscopy in combination with ADC ratio, rather than ADC value, can improve the ability to differentiate recurrent glioma and radiation injury."1.34Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging. ( Feng, DC; Li, CF; Liu, H; Zeng, QS; Zhen, JH, 2007)
"F98 gliomas were induced in 26 rats."1.33Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat. ( Biollaz, G; Buck, A; Goepfert, K; Lutz, A; Pahnke, J; Spaeth, N; Treyer, V; Weber, B; Westera, G; Wyss, MT, 2006)
"Ten patients with untreated gliomas were examined on a 1."1.32Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas. ( Buslei, R; Fahlbusch, R; Ganslandt, O; Gruber, S; Moser, E; Nimsky, C; Stadlbauer, A, 2004)
"Most of the brain tumors were characterized by strongly reduced total N-acetylaspartyl compounds and marked increases of myo-inositol and choline-containing compounds, consistent with a lack of neuroaxonal tissue and a proliferation of glial cells."1.31Quantitative proton magnetic resonance spectroscopy of focal brain lesions. ( Dechent, P; Frahm, J; Hanefeld, F; Herms, J; Markakis, E; Maxton, C; Wilken, B, 2000)
"The diagnosis of brain tumors after high-dose radiation therapy is frequently limited by the lack of metabolic discrimination available with conventional imaging methods."1.31Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery. ( Chang, S; Dillon, WP; Graves, EE; Larson, D; McDermott, M; Nelson, SJ; Prados, MD; Verhey, L; Vigneron, DB, 2001)
"High-grade brain tumors are known to have a high rate of glucose (Glc) consumption."1.31High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging. ( Décorps, M; Rémy, C; von Kienlin , M; Ziegler, A, 2001)
"First, it allows to distinguish brain tumors from abscesses."1.31[Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis]. ( Berry, I; Ibarrola, D; Malet-Martino, M; Sabatier, J, 2001)
"Seventeen brain tumors were measured by 1H-CSI (chemical shift imaging) in a 1."1.30Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method. ( Furuya, S; Ide, M; Kizu, O; Maeda, T; Morishita, H; Naruse, S; Ueda, S, 1997)
"Pediatric brain gliomas are not always amenable for complete surgical excision, therefore adjuvant treatment for a large tumor mass is often required."1.30Variation of post-treatment H-MRSI choline intensity in pediatric gliomas. ( Alger, J; Gupta, RK; Lazareff, JA, 1999)
"Choline signals were increased in tumour margins of high grade gliomas and more diffusely in low grade gliomas."1.29Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy. ( Go, KG; Heesters, MA; Kamman, RL; Mooyaart, EL, 1993)
"Higher grades of brain tumors in this study were associated with higher Cho/reference and lower NAA/reference values."1.29Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy. ( Arai, N; Fujiwara, S; Hara, K; Kayama, T; Kumabe, T; Ono, Y; Sato, K; Shimizu, H; Tominaga, T; Yoshimoto, T, 1996)
"Seventy patients with intracranial neoplasms were studied before receiving surgery, radiotherapy or chemotherapy."1.29Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives. ( Calabrese, G; Falini, A; Lipari, S; Losa, M; Origgi, D; Scotti, G; Triulzi, F, 1996)
" The dose-response curve for choline generation and DNA synthesis were comparable."1.28Activation of phospholipase D by platelet-derived growth factor (PDGF) in rat C6 glioma cells: possible role in mitogenic signal transduction. ( Nakashima, T; Nozawa, Y; Okano, Y; Sakai, N; Yamada, H; Zhang, W, 1992)

Research

Studies (240)

TimeframeStudies, this research(%)All Research%
pre-199019 (7.92)18.7374
1990's38 (15.83)18.2507
2000's87 (36.25)29.6817
2010's77 (32.08)24.3611
2020's19 (7.92)2.80

Authors

AuthorsStudies
Mišir Krpan, A1
Hodolič, M1
Golubić, AT1
Baučić, M1
Nemir, J1
Mrak, G1
Žuvić, M1
Huić, D1
Rudnay, M1
Waczulikova, I1
Bullova, A1
Rjaskova, G1
Chorvath, M1
Jezberova, M1
Lehotska, V1
Yang, C2
Wu, Y1
Wang, L1
Li, S1
Zhou, J1
Tan, Y1
Song, J1
Xing, H1
Yi, K1
Zhan, Q1
Zhao, J1
Wang, Q2
Yuan, X1
Kang, C1
García Vicente, AM8
Pena Pardo, FJ4
Amo-Salas, M3
Villena Martín, M4
López Menéndez, C2
Soriano Castrejón, ÁM4
Pérez-Beteta, J3
Wang, MH1
Roa, W1
Wachowicz, K1
Yahya, A1
Murtha, A1
Amanie, J1
Chainey, J1
Quon, H1
Ghosh, S1
Patel, S1
Bosque, JJ1
Pérez-García, VM2
Sandoval Valencia, H3
Lozano Setien, E2
Ferrazzoli, V3
Shankar, A3
Cockle, JV3
Tang, C3
Al-Khayfawee, A3
Bomanji, J3
Fraioli, F3
Hyare, H3
Tran, D3
Nguyen, DH3
Nguyen, HK3
Nguyen-Thanh, VA3
Dong-Van, H3
Nguyen, MD3
De Stefano, FA1
Morell, AA1
Smith, G1
Warner, T1
Soldozy, S1
Elarjani, T1
Eichberg, DG1
Luther, E1
Komotar, RJ1
Sheng, Y1
Yin, D1
Zeng, Q5
Yang, B1
Du, J1
Fang, J1
Li, G1
Wang, S3
Xu, Y3
Goryawala, M1
Saraf-Lavi, E1
Nagornaya, N1
Heros, D1
Komotar, R1
Maudsley, AA2
Fujita, Y1
Kohta, M1
Sasayama, T1
Tanaka, K1
Hashiguchi, M1
Nagashima, H1
Kyotani, K1
Nakai, T1
Ito, T2
Kohmura, E1
Wang, AP1
Suryavanshi, T1
Marcucci, M1
Fong, C1
Whitton, AC1
Reddy, KKV1
Cordero García, JM1
Borrás Moreno, JM3
Soriano Castrejón, A2
Kong, Z2
Jiang, C3
Liu, D2
Chen, W1
Ma, W2
Cheng, X2
Wang, Y4
Zhang, Y2
Liu, P1
Shi, Y1
Zhao, D1
Jiménez Aragón, F1
Jiménez Londoño, GA1
Ditter, P1
Hattingen, E9
Liu, Z1
Zhang, J4
Berrington, A1
Voets, NL1
Larkin, SJ1
de Pennington, N1
Mccullagh, J1
Stacey, R1
Schofield, CJ1
Jezzard, P1
Clare, S1
Cadoux-Hudson, T1
Plaha, P1
Ansorge, O1
Emir, UE1
Gao, W1
Wang, X3
Li, F4
Shi, W3
Li, H3
Pedrosa de Barros, N1
Meier, R1
Pletscher, M1
Stettler, S1
Knecht, U1
Herrmann, E1
Schucht, P1
Reyes, M1
Gralla, J1
Wiest, R1
Slotboom, J1
Gao, L1
Xu, W1
Li, T1
Zheng, J1
Chen, G1
Rodriguez Muñoz, MJ1
Martinez Madrigal, MM1
Chawla, S1
Lee, SC1
Mohan, S1
Nasrallah, M1
Vossough, A1
Krejza, J1
Melhem, ER1
Nabavizadeh, SA1
Mollejo Villanueva, M1
Barbella, R1
Klein Zampaña, CJ1
Li, J2
Huang, S1
Shao, K1
Liu, Y1
An, S2
Kuang, Y1
Guo, Y2
Ma, H2
Balos, DR1
Gavrilović, S2
Lavrnić, S2
Vasić, B1
Macvanski, M2
Damjanović, D2
Opinćal, TS1
Roder, C1
Skardelly, M1
Ramina, KF1
Beschorner, R1
Honneger, J1
Nägele, T1
Tatagiba, MS1
Ernemann, U1
Bisdas, S1
García-Álvarez, I1
Garrido, L1
Romero-Ramírez, L1
Nieto-Sampedro, M1
Fernández-Mayoralas, A1
Campos-Olivas, R1
Takenaka, S2
Asano, Y2
Shinoda, J3
Nomura, Y1
Yonezawa, S1
Miwa, K3
Yano, H2
Iwama, T3
Novak, J1
Wilson, M2
Macpherson, L1
Arvanitis, TN2
Davies, NP2
Peet, AC2
Raschke, F1
Jones, TL1
Barrick, TR1
Howe, FA1
Madan, A1
Ganji, SK2
An, Z1
Choe, KS1
Pinho, MC1
Bachoo, RM2
Maher, EM1
Choi, C2
Babourina-Brooks, B1
Li, W1
Ma, L1
Sun, J1
Hu, X1
Giovannini, E1
Lazzeri, P1
Milano, A1
Gaeta, MC1
Ciarmiello, A1
Stadler, KL1
Ober, CP1
Feeney, DA1
Jessen, CR1
Yamamoto, T1
Isobe, T3
Akutsu, H1
Masumoto, T1
Ando, H1
Sato, E1
Takada, K1
Anno, I3
Matsumura, A3
Gómez-Río, M1
Testart Dardel, N1
Santiago Chinchilla, A1
Rodríguez-Fernández, A1
Olivares Granados, G1
Luque Caro, R1
Zurita Herrera, M1
Chamorro Santos, CE1
Lardelli-Claret, P1
Llamas-Elvira, JM1
Hatazawa, J1
Ranjith, G1
Parvathy, R1
Vikas, V1
Chandrasekharan, K1
Nair, S1
Li, LF1
Taw, BB1
Pu, JK1
Hwang, GY1
Lui, WM1
Leung, GK1
Ghasemi, K1
Khanmohammadi, M1
Saligheh Rad, H1
Tong, T1
Yang, Z1
Chen, JW1
Zhu, J1
Yao, Z1
Tolia, M1
Verganelakis, D1
Tsoukalas, N1
Kyrgias, G1
Papathanasiou, M1
Mosa, E1
Kokakis, I1
Kouvaris, JR1
Pissakas, G1
Pistevou-Gombaki, K1
Kelekis, N1
Kouloulias, V1
Yang, H1
Jiang, X1
He, X1
Lotumolo, A2
Caivano, R2
Rabasco, P2
Iannelli, G1
Villonio, A2
D' Antuono, F1
Gioioso, M1
Zandolino, A2
Macarini, L2
Guglielmi, G1
Cammarota, A2
Zhang, H1
Wu, C1
Zhu, W1
Chen, X1
Xu, B1
Zhuang, DX1
Yao, CJ1
Lin, CP1
Wang, TL1
Qin, ZY1
Wu, JS1
Xu, YJ1
Cui, Y1
Li, HX1
Shi, WQ1
Li, FY1
Wang, JZ1
Zeng, QS3
Lowenstein, PR1
Castro, MG1
Roldan-Valadez, E1
Rios, C1
Motola-Kuba, D1
Matus-Santos, J1
Villa, AR1
Moreno-Jimenez, S1
Yi, C1
Raab, P3
Franz, K5
Lanfermann, H7
Setzer, M1
Gerlach, R2
Zanella, FE3
Pilatus, U8
Sankar, T2
Caramanos, Z3
Assina, R1
Villemure, JG1
Leblanc, R2
Langleben, A1
Arnold, DL4
Preul, MC3
Li, Y1
Srinivasan, R1
Ratiney, H1
Lu, Y3
Chang, SM5
Nelson, SJ7
Chernov, MF2
Muragaki, Y3
Maruyama, T3
Ono, Y3
Usukura, M1
Yoshida, S1
Nakamura, R1
Iseki, H1
Kubo, O2
Hori, T2
Takakura, K1
Alexiou, GA1
Polyzoidis, KS1
Voulgaris, S1
Tsiouris, S1
Fotopoulos, AD1
Kyritsis, AP1
Douis, H1
Jafri, M1
Sherlala, K1
Machová, E1
O'Regan, S1
Newcombe, J1
Meunier, FM1
Prentice, J1
Dove, R1
Lisá, V1
Dolezal, V1
Delic, O1
Nakajima, T1
Kumabe, T3
Kanamori, M1
Saito, R1
Tashiro, M1
Watanabe, M1
Tominaga, T2
Blamek, S1
Larysz, D1
Ficek, K1
Sokół, M2
Miszczyk, L1
Tarnawski, R1
Senft, C1
Schänzer, A1
Seifert, V1
Gasser, T1
Matsusue, E1
Fink, JR1
Rockhill, JK1
Ogawa, T1
Maravilla, KR1
Goenka, AH1
Kumar, A1
Sharma, R1
Kuznetsov, YE1
Ryan, RW1
Antel, SB1
Server, A3
Josefsen, R2
Kulle, B2
Maehlen, J1
Schellhorn, T1
Gadmar, Ø1
Kumar, T2
Haakonsen, M1
Langberg, CW1
Nakstad, PH2
Sijens, PE3
Slaets, D1
De Bruyne, S1
Dumolyn, C1
Moerman, L1
Mertens, K3
De Vos, F2
Stadlbauer, A5
Buchfelder, M2
Doelken, MT1
Hammen, T3
Ganslandt, O5
Gadmar, ØB1
Blasel, S1
Pfeilschifter, W1
Jansen, V1
Mueller, K1
Zanella, F2
Weber, MA1
Henze, M1
Tüttenberg, J1
Stieltjes, B1
Meissner, M1
Zimmer, F1
Burkholder, I1
Kroll, A1
Combs, SE1
Vogt-Schaden, M1
Giesel, FL1
Zoubaa, S1
Haberkorn, U1
Kauczor, HU1
Essig, M1
Liu, H3
Zhang, K2
Li, C1
Zhou, G1
Roselli, F1
Pisciotta, NM1
Aniello, MS1
Niccoli-Asabella, A1
Defazio, G1
Livrea, P1
Rubini, G1
Widhalm, G1
Krssak, M1
Minchev, G1
Wöhrer, A1
Traub-Weidinger, T1
Czech, T1
Asenbaum, S1
Marosi, C1
Knosp, E1
Hainfellner, JA1
Prayer, D1
Wolfsberger, S1
Lam, WW1
Ng, DC1
Wong, WY1
Ong, SC1
Yu, SW1
See, SJ1
Parekh, C1
Jubran, R1
Erdreich-Epstein, A1
Panigrahy, A1
Bluml, S1
Finlay, J1
Dhall, G1
Porto, L3
Kieslich, M2
Lehrbecher, T1
Wagner, M1
Nafe, R2
Jurcoane, A1
Rieger, J1
Steinbach, JP1
Robert, O1
Sabatier, J3
Desoubzdanne, D1
Lalande, J1
Balayssac, S1
Gilard, V2
Martino, R1
Malet-Martino, M3
Guillevin, R2
Menuel, C2
Vallée, JN2
Françoise, JP1
Capelle, L2
Habas, C2
De Marco, G2
Chiras, J2
Costalat, R2
Aki, T1
Yokoyama, K1
McKnight, TR8
Smith, KJ1
Chu, PW1
Chiu, KS1
Cloyd, CP1
Phillips, JJ1
Berger, MS3
Taillibert, S1
Abud, L1
Hoang-Xuan, K1
Ristic-Balos, D1
Gavrilov, M1
Milicevic, M1
Skender-Gazibara, M1
Stosic-Opincal, T1
Amin, A1
Moustafa, H1
Ahmed, E1
El-Toukhy, M1
Roelcke, U1
Bruehlmeier, M1
Hefti, M1
Hundsberger, T1
Nitzsche, EU1
Li, FM1
Nie, Q1
Wang, RM1
Zhao, WR1
Zhu, Q1
Liang, YK1
Yang, P1
Jia, HW1
Fang, HH1
Stuecher, A1
Herminghaus, S3
Ulrich Pilatus, UP1
DeBerardinis, RJ1
Hatanpaa, KJ1
Rakheja, D1
Kovacs, Z1
Yang, XL1
Mashimo, T1
Raisanen, JM1
Marin-Valencia, I1
Pascual, JM1
Madden, CJ1
Mickey, BE1
Malloy, CR1
Maher, EA1
Steffen-Smith, EA1
Venzon, DJ1
Bent, RS1
Hipp, SJ1
Warren, KE1
Acou, M1
Van den Broecke, C2
Nuyts, R1
Van Roost, D1
Achten, E1
Goethals, I2
Guo, J1
Yao, C1
Chen, H1
Zhuang, D1
Tang, W1
Ren, G1
Wu, J1
Huang, F1
Zhou, L1
Bolcaen, J1
Ham, H1
Deblaere, K1
Boterberg, T1
Shang, HB1
Zhao, WG1
Zhang, WF1
Pascual-Castroviejo, I1
Pascual-Pascual, SI1
Velazquez-Fragua, R1
Viaño, J1
Bulik, M1
Jancalek, R1
Vanicek, J1
Skoch, A1
Mechl, M1
D'Antuono, F1
Lancellotti, MI1
Rock, JP2
Hearshen, D2
Scarpace, L2
Croteau, D2
Gutierrez, J2
Fisher, JL2
Rosenblum, ML1
Mikkelsen, T2
von dem Bussche, MH1
Vigneron, DB4
McDermott, MW1
Dillon, WP4
Graves, EE2
Pirzkall, A3
Kokkinakis, DM1
Wick, JB1
Zhou, QX1
Rabinov, JD1
Lee, PL1
Barker, FG1
Louis, DN1
Harsh, GR1
Cosgrove, GR1
Chiocca, EA1
Thornton, AF1
Loeffler, JS1
Henson, JW1
Gonzalez, RG1
Viani, P1
Giussani, P1
Brioschi, L1
Bassi, R1
Anelli, V1
Tettamanti, G1
Riboni, L1
Bulakbasi, N2
Kocaoglu, M2
Ors, F1
Tayfun, C2
Uçöz, T1
Galanaud, D1
Nicoli, F1
Le Fur, Y2
Roche, P1
Confort-Gouny, S1
Dufour, H1
Ranjeva, JP2
Peragut, JC1
Viout, P1
Cozzone, PJ1
Nagatomo, Y1
Yoshizawa, T1
Itai, Y1
Nose, T1
Bénard, F1
Romsa, J1
Hustinx, R1
Harting, I1
Hartmann, M1
Jost, G1
Sommer, C1
Ahmadi, R1
Heiland, S1
Sartor, K1
Wagner, S1
Schneider, B1
Schlote, W1
Lehtimäki, KK2
Valonen, PK2
Griffin, JL2
Väisänen, TH1
Gröhn, OH2
Kettunen, MI1
Vepsäläinen, J1
Ylä-Herttuala, S1
Nicholson, J1
Kauppinen, RA3
Hara, T5
Kondo, T2
Kosaka, N2
Simonetti, AW1
Melssen, WJ1
van der Graaf, M1
Postma, GJ1
Heerschap, A2
Buydens, LM1
Murphy, PS2
Viviers, L1
Abson, C1
Rowland, IJ2
Brada, M1
Leach, MO2
Dzik-Jurasz, AS2
Bianchi, L1
De Micheli, E1
Bricolo, A1
Ballini, C1
Fattori, M1
Venturi, C1
Pedata, F1
Tipton, KF1
Della Corte, L1
Lee, MC1
Ando, K1
Ishikura, R1
Nagami, Y1
Morikawa, T1
Takada, Y1
Ikeda, J1
Nakao, N1
Matsumoto, T1
Arita, N1
Tong, Z2
Yamaki, T2
Harada, K2
Houkin, K2
Chiang, IC1
Kuo, YT1
Lu, CY1
Yeung, KW1
Lin, WC1
Sheu, FO1
Liu, GC1
Chen, CY1
Lirng, JF1
Chan, WP1
Fang, CL1
Batra, A1
Tripathi, RP1
Singh, AK1
Moser, E4
Gruber, S3
Buslei, R4
Nimsky, C4
Fahlbusch, R3
Magalhaes, A1
Godfrey, W1
Shen, Y1
Hu, J1
Smith, W1
Izumiyama, H1
Abe, T1
Tanioka, D1
Fukuda, A1
Kunii, N1
Floeth, FW1
Pauleit, D1
Wittsack, HJ1
Langen, KJ1
Reifenberger, G1
Hamacher, K1
Messing-Jünger, M1
Zilles, K1
Weber, F1
Stummer, W1
Steiger, HJ1
Woebker, G1
Müller, HW1
Coenen, H1
Sabel, M1
Ochiai, T1
Izawa, M1
Hayashi, M1
Kamada, K2
Blumcke, I1
Laprie, A1
Haas-Kogan, DA1
Cha, S3
Banerjee, A1
Le, TP1
Nelson, S1
Liimatainen, T1
Nicholson, JK1
Takano, S1
Kawamura, H1
Fayed, N2
Modrego, PJ2
Tong, ZY1
Toshiaki, Y1
Wang, YJ1
Balmaceda, C1
Critchell, D1
Mao, X1
Cheung, K1
Pannullo, S1
DeLaPaz, RL1
Shungu, DC1
Pulkkinen, J1
Häkkinen, AM1
Lundbom, N2
Paetau, A1
Hiltunen, Y1
Likavcanová, K1
Dobrota, D1
Liptaj, T1
Prónayová, N1
Mlynárik, V1
Belan, V1
Galanda, M1
Béres, A1
De Riggo, J1
Tomandl, B1
Spaeth, N2
Wyss, MT2
Pahnke, J2
Biollaz, G2
Lutz, A1
Goepfert, K1
Westera, G1
Treyer, V2
Weber, B2
Buck, A2
Morales, H1
Pina, MA1
Di Costanzo, A1
Scarabino, T1
Trojsi, F1
Giannatempo, GM1
Popolizio, T1
Catapano, D1
Bonavita, S2
Maggialetti, N1
Tosetti, M1
Salvolini, U1
d'Angelo, VA1
Tedeschi, G2
Kim, JH1
Chang, KH1
Na, DG1
Song, IC1
Kwon, BJ1
Han, MH1
Kim, K1
Goebell, E1
Fiehler, J1
Ding, XQ1
Paustenbach, S1
Nietz, S1
Heese, O1
Kucinski, T1
Hagel, C1
Westphal, M1
Zeumer, H1
Matulewicz, Ł1
Michnik, A1
Wydmański, J1
Fan, G1
Talbot, JN1
Kerrou, K1
Gault, N1
Gutman, F1
Grahek, D1
Touboul, E1
Schlienger, M1
Montravers, F1
Yan, B1
Schwabe, D1
Narayana, A1
Chang, J1
Thakur, S1
Huang, W1
Karimi, S1
Hou, B1
Kowalski, A1
Perera, G1
Holodny, A1
Gutin, PH1
Li, CF2
Zhen, JH2
Feng, DC1
Pinker, K1
Yerli, H1
Ağildere, AM1
Ozen, O1
Geyik, E1
Atalay, B1
Elhan, AH1
Alessi, P1
Trachsel, E1
Neri, D1
Lamborn, KR2
Love, TD1
Chang, S2
Bollen, A1
Kang, XS1
Zonari, P1
Baraldi, P1
Crisi, G1
Sanal, TH1
Alimenti, A1
Delavelle, J1
Lazeyras, F1
Yilmaz, H1
Dietrich, PY1
de Tribolet, N1
Lövblad, KO1
Heesters, MA2
Enting, RH1
van der Graaf, WT1
Potze, JH1
Irwan, R1
Meiners, LC1
Oudkerk, M2
Bansal, A1
Shuyan, W1
Harris, RA1
Degrado, TR1
Khayal, IS1
Crawford, FW1
Saraswathy, S1
Kato, T1
Nakayama, N1
Okumura, A1
Yoshimura, S1
Weber, MJ1
McGee, R2
Walum, E2
Poduslo, SE1
Miller, K1
Jang, Y1
Smith, C1
Christian, C2
Mata, M1
Nelson, P2
Nirenberg, M3
Hagberg, G1
Burlina, AP1
Mader, I1
Roser, W1
Radue, EW1
Seelig, J1
Poptani, H1
Gupta, RK2
Roy, R1
Pandey, R1
Jain, VK1
Chhabra, DK1
de Graaf, RA1
Luo, Y1
Terpstra, M1
Garwood, M1
Kinoshita, Y2
Kajiwara, H1
Yokota, A2
Koga, Y1
Harada, M1
Tanouchi, M1
Nishitani, H1
Miyoshi, H1
Bandou, K1
Kannuki, S1
Castillo, M1
Green, C1
Kwock, L1
Smith, K1
Wilson, D1
Schiro, S1
Greenwood, R1
Cazzaniga, S1
Schold, SC1
Sostman, HD1
Charles, HC1
Gyngell, ML2
Els, T1
Hoehn-Berlage, M1
Hossmann, KA1
Gillies, RJ1
Barry, JA1
Ross, BD1
Kamman, RL1
Mooyaart, EL1
Go, KG1
Barker, PB1
Blackband, SJ1
Chatham, JC1
Soher, BJ1
Samphilipo, MA1
Magee, CA1
Hilton, JD1
Strandberg, JD1
Anderson, JH1
Rémy, C3
Arús, C1
Ziegler, A3
Lai, ES1
Moreno, A1
Décorps, M2
Felber, SR1
Xu, Z1
Byers, DM6
Palmer, FB5
Spence, MW5
Cook, HW6
Negendank, WG1
Sauter, R2
Brown, TR1
Evelhoch, JL1
Falini, A2
Gotsis, ED1
Lee, BC1
Mengeot, MM1
Padavic-Shaller, KA1
Sanders, JA1
Spraggins, TA1
Stillman, AE1
Terwey, B1
Vogl, TJ1
Wicklow, K1
Zimmerman, RA1
Shimizu, H2
Kayama, T1
Hara, K1
Sato, K1
Arai, N1
Fujiwara, S1
Yoshimoto, T2
Sproull, SA1
Morash, SC1
Calabrese, G1
Origgi, D1
Lipari, S1
Triulzi, F1
Losa, M1
Scotti, G1
Broniscer, A1
Gajjar, A1
Bhargava, R1
Langston, JW1
Heideman, R1
Jones, D1
Kun, LE1
Taylor, J1
Shinoura, N1
Nishijima, M1
Haisa, T1
Yamamoto, H1
Fujii, K1
Mitsui, I1
Rodríguez, FD1
Alling, C1
Gustavsson, L1
Furuya, S1
Naruse, S1
Ide, M1
Morishita, H1
Kizu, O1
Ueda, S1
Maeda, T1
Raman, R1
Duyn, JH1
Alger, JR1
Di Chiro, G1
Burtscher, IM1
Ståhlberg, F1
Holtås, S1
Morreale, A1
Mallon, B1
Beale, G1
Watson, J1
Rumsby, M1
Kasrai, R1
Narayanan, S1
van Dijk, P1
Levendag, PC1
Vecht, CJ1
Terral, C1
Breil, S1
Delisle, MB1
Manelfe, C1
Tremoulet, M1
Berry, I2
Siemen, D1
Loupatatzis, C1
Borecky, J1
Gulbins, E1
Lang, F1
Lazareff, JA1
Alger, J1
Henry, RG1
Fischbein, NJ1
Grant, PE1
Day, MR1
Noworolski, SM2
Star-Lack, JM1
Wald, LL1
Shirane, R1
Wilken, B1
Dechent, P1
Herms, J1
Maxton, C1
Markakis, E1
Hanefeld, F1
Frahm, J2
Nelson , SJ1
Verhey, L1
McDermott, M1
Larson, D1
Prados, MD1
von Kienlin , M1
García-Martín, ML1
Hérigault, G1
Farion, R1
Ballesteros, P1
Coles, JA1
Cerdán, S1
Ibarrola, D1
Träber, F1
Block, W1
Flacke, S1
Lamerichs, R1
Schüller, H1
Urbach, H1
Keller, E1
Schild, HH1
Ng, SH1
Ko, SF1
Chen, WC1
Tang, LM1
Chang, CN1
Wai, YY1
Wan, YL1
Law, M1
Knopp, EA1
Johnson, G1
Arnett, J1
Litt, AW1
Möller-Hartmann, W1
Krings, T1
Marquardt, G1
Lazarewicz, JW1
Kanje, M1
Sellström, A1
Hamberger, A1
Massarelli, R1
Mandel, P1
Zhang, W1
Nakashima, T1
Sakai, N1
Yamada, H1
Okano, Y1
Nozawa, Y1
Matthews, PM1
Francis, GS1
O'Connor, J1
Antel, JP1
Rouzaire-Dubois, B1
Dubois, JM1
Wei, JW1
Yeh, SR1
George, TP2
Mokrasch, LC1
Bruhn, H1
Merboldt, KD1
Hänicke, W1
Hamburger, C1
Liscovitch, M2
Slack, B1
Blusztajn, JK2
Wurtman, RJ2
Freese, A1
Sandberg, K1
Schnaar, RL1
McKinney, M1
Hanin, I1
Fisher, A1
Coyle, JT1
Matsuoka, I1
Satake, R1
Kurihara, K1
Schrier, BK1
Wilson, SH1
Patterson, PH1
Chun, LL1
Amano, T1
Hamprecht, B1
Kemper, W1

Clinical Trials (6)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Multi-paramEtric Imaging to Assess Treatment REsponse After Stereotactic Radiosurgery of Brain Metastases[NCT04626206]12 participants (Anticipated)Observational2020-12-31Not yet recruiting
A Prospective Study About the Validity of MRS-guided Resection on Prognosis High-grade Gliomas[NCT02795364]50 participants (Anticipated)Interventional2016-06-30Not yet recruiting
Treatment Development of Triheptanoin for Glucose Transporter Type I Deficiency[NCT02021526]Phase 1/Phase 20 participants (Actual)Interventional2015-12-31Withdrawn (stopped due to NIH funding resulted in new clinical trial)
Metabolic Characterization of Space Occupying Lesions of the Brain Using in Vivo MR- (Spectroscopic) Imaging at 3 Tesla and 7 Tesla[NCT04233788]55 participants (Anticipated)Observational2021-09-01Recruiting
Combination of 11C-MET PET and MRS in the Diagnosis of Glioma.[NCT03009318]100 participants (Actual)Interventional2012-01-31Completed
Study of Clinical Biomarkers in Human Health and Disease (Healthiomics)[NCT05106725]3,500 participants (Anticipated)Observational2021-10-11Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

12 reviews available for choline and Glioma

ArticleYear
Unique magnetic resonance spectroscopy profile of intracranial meningiomas compared to gliomas: a systematic review.
    Acta neurologica Belgica, 2023, Volume: 123, Issue:6

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Female; Glioma; Humans; Magnetic Resonance Spectr

2023
Accuracy of 11C-choline positron emission tomography in differentiating glioma recurrence from radiation necrosis: A systematic review and meta-analysis.
    Medicine, 2018, Volume: 97, Issue:29

    Topics: Carbon Radioisotopes; Choline; Diagnosis, Differential; Glioma; Humans; Necrosis; Neoplasm Recurrenc

2018
Clinical applications of choline PET/CT in brain tumors.
    Current pharmaceutical design, 2015, Volume: 21, Issue:1

    Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Glioma; Half-Life; Humans; P

2015
The diagnostic performance of magnetic resonance spectroscopy in differentiating high-from low-grade gliomas: A systematic review and meta-analysis.
    European radiology, 2016, Volume: 26, Issue:8

    Topics: Area Under Curve; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Databases, Factual; Glioma; Hum

2016
The Long and Winding Road: From the High-Affinity Choline Uptake Site to Clinical Trials for Malignant Brain Tumors.
    Advances in pharmacology (San Diego, Calif.), 2016, Volume: 76

    Topics: Adenoviridae; Animals; Brain Neoplasms; Choline; Dendritic Cells; Genetic Therapy; Genetic Vectors;

2016
[Corpus callosum tumor as the presenting symptom of neurofibromatosis type 1 in a patient and literature review].
    Revista de neurologia, 2012, Nov-01, Volume: 55, Issue:9

    Topics: Brain Neoplasms; Brain Stem Neoplasms; Cerebellar Neoplasms; Child, Preschool; Choline; Corpus Callo

2012
Potential of MR spectroscopy for assessment of glioma grading.
    Clinical neurology and neurosurgery, 2013, Volume: 115, Issue:2

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Glioma; Humans; Inositol; Lactates; Lipid Metabol

2013
3 Tesla magnetic resonance spectroscopy: cerebral gliomas vs. metastatic brain tumors. Our experience and review of the literature.
    The International journal of neuroscience, 2013, Volume: 123, Issue:8

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Diagnosis, Differ

2013
Imaging gliomas with positron emission tomography and single-photon emission computed tomography.
    Seminars in nuclear medicine, 2003, Volume: 33, Issue:2

    Topics: Brain; Brain Neoplasms; Choline; Fluorodeoxyglucose F18; Glioma; Methionine; Methyltyrosines; Predic

2003
Proton magnetic resonance spectroscopic evaluation of brain tumor metabolism.
    Seminars in oncology, 2004, Volume: 31, Issue:5

    Topics: Alanine; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Glioma; Glutamic Acid; Glutamine; Humans

2004
[PET and malignant cerebral tumors].
    Presse medicale (Paris, France : 1983), 2006, Volume: 35, Issue:9 Pt 2

    Topics: Brain Neoplasms; Choline; Dideoxynucleosides; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Glioma

2006
Brain stem involvement in children with neurofibromatosis type 1: role of magnetic resonance imaging and spectroscopy in the distinction from diffuse pontine glioma.
    Neurosurgery, 1997, Volume: 40, Issue:2

    Topics: Adolescent; Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Child, Preschool; Choline; Creatine;

1997

Trials

11 trials available for choline and Glioma

ArticleYear
18F-Fluorocholine PET/CT in the Prediction of Molecular Subtypes and Prognosis for Gliomas.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:10

    Topics: Choline; Chromosome Deletion; Disease Progression; Female; Glioma; Humans; Isocitrate Dehydrogenase;

2019
Evaluation of human glioma using in-vivo proton magnetic resonance spectroscopy combined with expression of cyclooxygenase-2: a preliminary clinical trial.
    Neuroreport, 2017, May-03, Volume: 28, Issue:7

    Topics: Adult; Aged; Biomarkers, Tumor; Brain; Brain Neoplasms; Choline; Creatine; Cyclooxygenase 2; Female;

2017
Prospective serial proton MR spectroscopic assessment of response to tamoxifen for recurrent malignant glioma.
    Journal of neuro-oncology, 2008, Volume: 90, Issue:1

    Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Dis

2008
11C-CHO PET in optimization of target volume delineation and treatment regimens in postoperative radiotherapy for brain gliomas.
    Nuclear medicine and biology, 2012, Volume: 39, Issue:3

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Carbon Radioisotopes; Child; Choline; Female; Follow-Up St

2012
The optimal timing for imaging brain tumours and other brain lesions with 18F-labelled fluoromethylcholine: a dynamic positron emission tomography study.
    Nuclear medicine communications, 2012, Volume: 33, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Glioma; Humans; Male; Middle Aged; Neoplasm Grading;

2012
Monitoring temozolomide treatment of low-grade glioma with proton magnetic resonance spectroscopy.
    British journal of cancer, 2004, Feb-23, Volume: 90, Issue:4

    Topics: Administration, Oral; Adult; Antineoplastic Agents, Alkylating; Brain Neoplasms; Choline; Dacarbazin

2004
Distinction between high-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings.
    Neuroradiology, 2004, Volume: 46, Issue:8

    Topics: Adult; Aged; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Choli

2004
Contrast/Noise ratio on conventional MRI and choline/creatine ratio on proton MRI spectroscopy accurately discriminate low-grade from high-grade cerebral gliomas.
    Academic radiology, 2006, Volume: 13, Issue:6

    Topics: Adolescent; Adult; Aged; Algorithms; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Fe

2006
Correlation of magnetic resonance spectroscopic and growth characteristics within Grades II and III gliomas.
    Journal of neurosurgery, 2007, Volume: 106, Issue:4

    Topics: Antibodies, Antinuclear; Antibodies, Monoclonal; Apoptosis; Aspartic Acid; Brain Neoplasms; Cell Pro

2007
Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Journal of neuro-oncology, 2007, Volume: 84, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Fema

2007
Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study.
    Journal of neurosurgery, 1996, Volume: 84, Issue:3

    Topics: Adolescent; Adult; Aged; Analysis of Variance; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Pr

1996

Other Studies

217 other studies available for choline and Glioma

ArticleYear
18F-FET and 18F-choline PET-CT in patients with MRI-suspected low-grade gliomas: a pilot study.
    Croatian medical journal, 2021, Aug-31, Volume: 62, Issue:4

    Topics: Brain Neoplasms; Choline; Glioma; Humans; Magnetic Resonance Imaging; Pilot Projects; Positron Emiss

2021
Magnetic resonance spectroscopy - its added value in brain glioma multiparametric assessment.
    Bratislavske lekarske listy, 2021, Volume: 122, Issue:10

    Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Glioma; Humans; Magnetic Resonance Spectro

2021
Glioma-derived exosomes hijack the blood-brain barrier to facilitate nanocapsule delivery via LCN2.
    Journal of controlled release : official journal of the Controlled Release Society, 2022, Volume: 345

    Topics: Blood-Brain Barrier; Choline; Endothelial Cells; Exosomes; Glioblastoma; Glioma; Humans; Lipocalin-2

2022
Prognostic Potential of Postoperative 18F-Fluorocholine PET/CT in Patients With High-Grade Glioma. Clinical Validation of FuMeGA Postoperative PET Criteria.
    Clinical nuclear medicine, 2022, Jun-01, Volume: 47, Issue:6

    Topics: Choline; Glioma; Humans; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomograph

2022
Early Metabolic Changes in 1H-MRSI Predictive for Survival in Patients With Newly Diagnosed High-grade Glioma.
    Anticancer research, 2022, Volume: 42, Issue:5

    Topics: Brain Neoplasms; Choline; Creatine; Glioma; Humans; Magnetic Resonance Imaging; Magnetic Resonance S

2022
Multiple and Diffuse Gliomas by 18F-Fluorocholine PET/CT: Two Sides of the Same Coin.
    Clinical nuclear medicine, 2022, Jun-01, Volume: 47, Issue:6

    Topics: Choline; Glioma; Humans; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals

2022
Early Recurrence Detection of Glioma Using 18 F-Fluorocholine PET/CT : GliReDe Pilot Study.
    Clinical nuclear medicine, 2022, Oct-01, Volume: 47, Issue:10

    Topics: Choline; Early Diagnosis; Glioma; Humans; Neoplasm Recurrence, Local; Pilot Projects; Positron Emiss

2022
Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
    Nuclear medicine communications, 2023, Jan-01, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Choline; Diffusion Magnetic Resonance Imaging; Glioma; Hu

2023
Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
    Nuclear medicine communications, 2023, Jan-01, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Choline; Diffusion Magnetic Resonance Imaging; Glioma; Hu

2023
Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
    Nuclear medicine communications, 2023, Jan-01, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Choline; Diffusion Magnetic Resonance Imaging; Glioma; Hu

2023
Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
    Nuclear medicine communications, 2023, Jan-01, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Choline; Diffusion Magnetic Resonance Imaging; Glioma; Hu

2023
Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
    Nuclear medicine communications, 2023, Jan-01, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Choline; Diffusion Magnetic Resonance Imaging; Glioma; Hu

2023
Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
    Nuclear medicine communications, 2023, Jan-01, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Choline; Diffusion Magnetic Resonance Imaging; Glioma; Hu

2023
Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
    Nuclear medicine communications, 2023, Jan-01, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Choline; Diffusion Magnetic Resonance Imaging; Glioma; Hu

2023
Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
    Nuclear medicine communications, 2023, Jan-01, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Choline; Diffusion Magnetic Resonance Imaging; Glioma; Hu

2023
Mapping glioma heterogeneity using multiparametric 18 F-choline PET/MRI in childhood and teenage-young adults.
    Nuclear medicine communications, 2023, Jan-01, Volume: 44, Issue:1

    Topics: Adolescent; Adult; Brain Neoplasms; Child; Choline; Diffusion Magnetic Resonance Imaging; Glioma; Hu

2023
Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:21

    Topics: Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Choline; Creatine; Glioma; Humans; Magnetic Reson

2022
Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:21

    Topics: Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Choline; Creatine; Glioma; Humans; Magnetic Reson

2022
Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:21

    Topics: Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Choline; Creatine; Glioma; Humans; Magnetic Reson

2022
Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:21

    Topics: Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Choline; Creatine; Glioma; Humans; Magnetic Reson

2022
Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:21

    Topics: Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Choline; Creatine; Glioma; Humans; Magnetic Reson

2022
Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:21

    Topics: Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Choline; Creatine; Glioma; Humans; Magnetic Reson

2022
Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:21

    Topics: Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Choline; Creatine; Glioma; Humans; Magnetic Reson

2022
Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:21

    Topics: Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Choline; Creatine; Glioma; Humans; Magnetic Reson

2022
Diagnostic performance of MRI perfusion and spectroscopy for brainstem glioma grading.
    European review for medical and pharmacological sciences, 2022, Volume: 26, Issue:21

    Topics: Aspartic Acid; Brain Neoplasms; Brain Stem; Child; Choline; Creatine; Glioma; Humans; Magnetic Reson

2022
Using the metabolite alterations monitoring the AEG-1 expression level and cell biological behaviour of U251 cell in vitro.
    PloS one, 2023, Volume: 18, Issue:9

    Topics: Astrocytes; Choline; Gene Expression; Glioma; Humans; Lactic Acid; Oncogenes

2023
Chordoid glioma: an entity occurring not exclusively in the third ventricle.
    Neurosurgical review, 2020, Volume: 43, Issue:5

    Topics: Adult; Aged; Aspartic Acid; Cerebellum; Cerebral Ventricle Neoplasms; Choline; Diffusion Magnetic Re

2020
The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2020, Volume: 30, Issue:1

    Topics: Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Female; Glioma; Humans; Isocitrate

2020
Intraoperative 3-T Magnetic Resonance Spectroscopy for Detection of Proliferative Remnants of Glioma.
    World neurosurgery, 2020, Volume: 137

    Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Neoplasms; Choline; Creatine; Female; Glioma; Humans; M

2020
Radiation Necrosis Following Stereotactic Radiosurgery for Trigeminal Neuralgia.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2020, Volume: 47, Issue:3

    Topics: Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neoplasms; Choline; Creatine; Diagnostic Err

2020
Low-Grade Versus High-Grade Glioma… That Is the Question. 18F-Fluorocholine PET in the Detection of Anaplastic Focus.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:5

    Topics: Brain Neoplasms; Choline; Glioma; Humans; Magnetic Resonance Imaging; Neoplasm Grading; Neovasculari

2020
FuMeGA Criteria for Visual Assessment of Postoperative 18F-Fluorocholine PET in Patients With Glioma.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:6

    Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Glioma; Humans; Image Processing, Computer-Assisted;

2020
Quantitative Features From CHO PET Distinguish the WHO Grades of Primary Diffuse Glioma.
    Clinical nuclear medicine, 2021, Feb-01, Volume: 46, Issue:2

    Topics: Adult; Aged; Area Under Curve; Brain Neoplasms; Choline; Diagnosis, Differential; Female; Glioma; Hu

2021
Role of traditional CHO PET parameters in distinguishing IDH, TERT and MGMT alterations in primary diffuse gliomas.
    Annals of nuclear medicine, 2021, Volume: 35, Issue:4

    Topics: Adult; Aged; Biomarkers, Tumor; Choline; DNA Modification Methylases; DNA Repair Enzymes; Female; Gl

2021
18F-Fluorocholine PET/CT, Brain MRI, and 5-Aminolevulinic Acid for the Assessment of Tumor Resection in High-Grade Glioma.
    Clinical nuclear medicine, 2017, Volume: 42, Issue:6

    Topics: Aminolevulinic Acid; Brain; Brain Neoplasms; Choline; Glioma; Humans; Magnetic Resonance Imaging; Ma

2017
[Magnetic resonance spectroscopy of brain tumors].
    Der Radiologe, 2017, Volume: 57, Issue:6

    Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Glioma; Humans; Magnetic Resonance Imaging

2017
Age, choline-to-N-acetyl aspartate, and lipids-lactate-to-creatine ratios assemble a significant Cox's proportional-hazards regression model for survival prediction in patients with high-grade gliomas.
    The British journal of radiology, 2017, Volume: 90, Issue:1075

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Glioma; Humans; Lactic Acid; Lipids; Magnetic Res

2017
A comparison of 2-hydroxyglutarate detection at 3 and 7 T with long-TE semi-LASER.
    NMR in biomedicine, 2018, Volume: 31, Issue:3

    Topics: Adult; Brain Neoplasms; Choline; Creatine; Female; Glioma; Glutarates; Humans; Isocitrate Dehydrogen

2018
Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Acta radiologica (Stockholm, Sweden : 1987), 2019, Volume: 60, Issue:1

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Biomarkers; Brain; Brain Neoplasms; Cell Proliferation; Chil

2019
On the relation between MR spectroscopy features and the distance to MRI-visible solid tumor in GBM patients.
    Magnetic resonance in medicine, 2018, Volume: 80, Issue:6

    Topics: Algorithms; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Glioma; Healthy Volunteers; Hu

2018
Lesion segmentation for MR spectroscopic imaging using the convolution difference method.
    Magnetic resonance in medicine, 2019, Volume: 81, Issue:3

    Topics: Algorithms; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Computer Simulation; Glio

2019
Ischemic Complications After High-Grade Glioma Resection Could Interfere With Residual Tumor Detection With 18F-Fluorocholine PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:2

    Topics: Adult; Brain Ischemia; Brain Neoplasms; Choline; Diagnosis, Differential; Female; Glioma; Humans; Ma

2019
Lack of choline elevation on proton magnetic resonance spectroscopy in grade I-III gliomas.
    The neuroradiology journal, 2019, Volume: 32, Issue:4

    Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Glioma; Humans; Magnetic Resonance Imaging; Male; Mid

2019
A choline derivate-modified nanoprobe for glioma diagnosis using MRI.
    Scientific reports, 2013, Volume: 3

    Topics: Animals; Brain Neoplasms; Choline; Contrast Media; Glioma; Image Enhancement; Magnetic Resonance Ima

2013
Proton magnetic resonance spectroscopy and apparent diffusion coefficient in evaluation of solid brain lesions.
    Vojnosanitetski pregled, 2013, Volume: 70, Issue:7

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Child; Choline; Creatine; Diffusion

2013
Spectroscopy imaging in intraoperative MR suite: tissue characterization and optimization of tumor resection.
    International journal of computer assisted radiology and surgery, 2014, Volume: 9, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Female; Glioma; Humans; Image

2014
The effect of antitumor glycosides on glioma cells and tissues as studied by proton HR-MAS NMR spectroscopy.
    PloS one, 2013, Volume: 8, Issue:10

    Topics: Analysis of Variance; Animals; Antineoplastic Agents; Cell Death; Cell Line, Tumor; Cell Proliferati

2013
Comparison of (11)C-methionine, (11)C-choline, and (18)F-fluorodeoxyglucose-PET for distinguishing glioma recurrence from radiation necrosis.
    Neurologia medico-chirurgica, 2014, Volume: 54, Issue:4

    Topics: Adult; Aged; Area Under Curve; Brain; Brain Neoplasms; Carbon Isotopes; Choline; Combined Modality T

2014
Clinical protocols for ³¹P MRS of the brain and their use in evaluating optic pathway gliomas in children.
    European journal of radiology, 2014, Volume: 83, Issue:2

    Topics: Adult; Analysis of Variance; Biomarkers, Tumor; Brain; Child, Preschool; Choline; Female; Glioma; Hu

2014
Delineation of gliomas using radial metabolite indexing.
    NMR in biomedicine, 2014, Volume: 27, Issue:9

    Topics: Algorithms; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Diagnosis, Computer-Assisted

2014
Proton T2 measurement and quantification of lactate in brain tumors by MRS at 3 Tesla in vivo.
    Magnetic resonance in medicine, 2015, Volume: 73, Issue:6

    Topics: Adult; Aged; Artifacts; Aspartic Acid; Brain Chemistry; Brain Neoplasms; Choline; Creatine; Female;

2015
MRS water resonance frequency in childhood brain tumours: a novel potential biomarker of temperature and tumour environment.
    NMR in biomedicine, 2014, Volume: 27, Issue:10

    Topics: Adolescent; Algorithms; Biomarkers, Tumor; Body Water; Brain Neoplasms; Cerebellar Neoplasms; Child;

2014
(11)C-choline PET/CT tumor recurrence detection and survival prediction in post-treatment patients with high-grade gliomas.
    Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2014, Volume: 35, Issue:12

    Topics: Adult; Aged; Brain; Brain Neoplasms; Choline; Female; Follow-Up Studies; Glioma; Humans; Magnetic Re

2014
Multivoxel proton magnetic resonance spectroscopy of inflammatory and neoplastic lesions of the canine brain at 3.0 T.
    American journal of veterinary research, 2014, Volume: 75, Issue:11

    Topics: Analysis of Variance; Animals; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Diagnosis,

2014
Influence of echo time in quantitative proton MR spectroscopy using LCModel.
    Magnetic resonance imaging, 2015, Volume: 33, Issue:5

    Topics: Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Glioma; Humans; Image Processing, Computer

2015
¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma: diagnostic accuracy and clinical utility.
    European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:6

    Topics: Adult; Brain Neoplasms; Choline; Female; Glioma; Humans; Male; Middle Aged; Multimodal Imaging; Posi

2015
¹⁸F-Fluorocholine PET/CT as a complementary tool in the follow-up of low-grade glioma.
    European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:6

    Topics: Brain Neoplasms; Choline; Female; Glioma; Humans; Male; Positron-Emission Tomography; Radiopharmaceu

2015
Machine learning methods for the classification of gliomas: Initial results using features extracted from MR spectroscopy.
    The neuroradiology journal, 2015, Volume: 28, Issue:2

    Topics: Algorithms; Artificial Intelligence; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Cre

2015
Primary Central Nervous System Natural Killer Cell Lymphoma in a Chinese Woman with Atypical (11)C-Choline Positron Emission Tomography and Magnetic Resonance Spectrometry Findings.
    World neurosurgery, 2015, Volume: 84, Issue:4

    Topics: Adult; Central Nervous System Neoplasms; Choline; Female; Fluorodeoxyglucose F18; Glioma; Humans; Ki

2015
Accurate grading of brain gliomas by soft independent modeling of class analogy based on non-negative matrix factorization of proton magnetic resonance spectra.
    Magnetic resonance in chemistry : MRC, 2016, Volume: 54, Issue:2

    Topics: Algorithms; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Glioma; Glycine; Humans; Neoplasm Gra

2016
Dynamic 1H-MRS assessment of brain tumors: a novel approach for differential diagnosis of glioma.
    Oncotarget, 2015, Oct-13, Volume: 6, Issue:31

    Topics: Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Case-Control Studies; Choline; Diagnosis, Differe

2015
Prognostic Value of MRS Metabolites in Postoperative Irradiated High Grade Gliomas.
    BioMed research international, 2015, Volume: 2015

    Topics: Adult; Age Factors; Aged; Choline; Creatine; Disease-Free Survival; Female; Glioma; Humans; Magnetic

2015
Choline Derivate-Modified Doxorubicin Loaded Micelle for Glioma Therapy.
    ACS applied materials & interfaces, 2015, Sep-30, Volume: 7, Issue:38

    Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Choline; Doxorubicin; Flow Cytometry; Glioma; Human

2015
Comparison between magnetic resonance spectroscopy and diffusion weighted imaging in the evaluation of gliomas response after treatment.
    European journal of radiology, 2015, Volume: 84, Issue:12

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Neoplasms; Choline; Diffusion Magnetic Resonanc

2015
Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
    Journal of neurosurgery, 2016, Volume: 124, Issue:6

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Diffusion Tensor Imaging; Feasibility S

2016
Noninvasive evaluation of radiation-enhanced glioma cells invasiveness by ultra-high-field (1)H-MRS in vitro.
    Magnetic resonance imaging, 2016, Volume: 34, Issue:8

    Topics: Aspartic Acid; Brain Neoplasms; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Choline; C

2016
Choline-to-N-acetyl aspartate and lipids-lactate-to-creatine ratios together with age assemble a significant Cox's proportional-hazards regression model for prediction of survival in high-grade gliomas.
    The British journal of radiology, 2016, Volume: 89, Issue:1067

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biomarkers; Brain Neoplasms; Choline; Cre

2016
Assessment of alterations in X-ray irradiation-induced DNA damage of glioma cells by using proton nuclear magnetic resonance spectroscopy.
    The international journal of biochemistry & cell biology, 2017, Volume: 84

    Topics: Apoptosis; Astrocytes; Brain Neoplasms; Cell Cycle; Cell Line, Tumor; Cell Survival; Choline; Creati

2017
Prognostic value of choline and creatine in WHO grade II gliomas.
    Neuroradiology, 2008, Volume: 50, Issue:9

    Topics: Adult; Aged; Brain Neoplasms; Choline; Creatine; Disease-Free Survival; Female; Follow-Up Studies; G

2008
Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T.
    Journal of magnetic resonance imaging : JMRI, 2008, Volume: 28, Issue:2

    Topics: Adult; Analysis of Variance; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Female; Gliom

2008
Oral administration of choline does not affect metabolic characteristics of gliomas and normal-appearing white matter, as detected with single-voxel (1)H-MRS at 1.5 T.
    Neuroradiology, 2009, Volume: 51, Issue:3

    Topics: Adult; Brain Neoplasms; Choline; Female; Glioma; Humans; Magnetic Resonance Imaging; Magnetic Resona

2009
Technetium Tc99m tetrofosmin single-photon emission CT for the assessment of glioma proliferation.
    AJNR. American journal of neuroradiology, 2008, Volume: 29, Issue:10

    Topics: Adult; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Gene Expressi

2008
Bilateral thalamic glioma.
    Archives of neurology, 2008, Volume: 65, Issue:12

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Female; Glioma; Humans; Magnetic Resonance Imagin

2008
Detection of choline transporter-like 1 protein CTL1 in neuroblastoma x glioma cells and in the CNS, and its role in choline uptake.
    Journal of neurochemistry, 2009, Volume: 110, Issue:4

    Topics: Acetylcholine; Animals; Antibody Specificity; Antigens, CD; Cell Differentiation; Cell Enlargement;

2009
(1)H MRSI and progression-free survival in patients with WHO grades II and III gliomas.
    Neurological research, 2010, Volume: 32, Issue:6

    Topics: Adult; Aged; Brain Neoplasms; Choline; Creatine; Disease Progression; Disease-Free Survival; Female;

2010
Differential diagnosis between radiation necrosis and glioma progression using sequential proton magnetic resonance spectroscopy and methionine positron emission tomography.
    Neurologia medico-chirurgica, 2009, Volume: 49, Issue:9

    Topics: Adolescent; Adult; Aged; Biomarkers; Brain; Brain Neoplasms; Carbon Radioisotopes; Choline; Diagnosi

2009
MR spectroscopic evaluation of brain tissue damage after treatment for pediatric brain tumors.
    Acta neurochirurgica. Supplement, 2010, Volume: 106

    Topics: Adolescent; Aspartic Acid; Brain; Brain Neoplasms; Child; Choline; Creatine; Ependymoma; Female; Gli

2010
Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
    Neurosurgery, 2009, Volume: 65, Issue:5

    Topics: Adult; Brain Neoplasms; Choline; Creatine; Glioma; Humans; Image Processing, Computer-Assisted; Magn

2009
Distinction between glioma progression and post-radiation change by combined physiologic MR imaging.
    Neuroradiology, 2010, Volume: 52, Issue:4

    Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Cerebrovascular Circulation; Choline; Cr

2010
MR spectroscopy for differentiation of recurrent glioma from radiation-induced changes.
    AJR. American journal of roentgenology, 2009, Volume: 193, Issue:6

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Child; Child, Preschool; Choline; Contrast

2009
The metabolic epicenter of supratentorial gliomas: a 1H-MRSI study.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2009, Volume: 36, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Aspartic Acid; Chi-Square Distribution; Cholin

2009
Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Acta radiologica (Stockholm, Sweden : 1987), 2010, Volume: 51, Issue:3

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Biomarkers; Brain Neoplasms; Choline; Contrast Media;

2010
Response to article "Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors".
    Acta radiologica (Stockholm, Sweden : 1987), 2010, Volume: 51, Issue:3

    Topics: Aspartic Acid; Biomarkers; Brain Neoplasms; Choline; Creatinine; Edema; Glioma; Humans; Image Enhanc

2010
Response to a letter by Paul E. Sijens.
    Acta radiologica (Stockholm, Sweden : 1987), 2010, Volume: 51, Issue:3

    Topics: Aspartic Acid; Biomarkers; Brain Neoplasms; Choline; Creatinine; Edema; Glioma; Humans; Image Enhanc

2010
Reduced dimethylaminoethanol in [(18)F]fluoromethylcholine: an important step towards enhanced tumour visualization.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:11

    Topics: Animals; Artifacts; Biological Transport; Cell Line, Tumor; Cell Transformation, Neoplastic; Chemica

2010
Magnetic resonance spectroscopic imaging for visualization of the infiltration zone of glioma.
    Central European neurosurgery, 2011, Volume: 72, Issue:2

    Topics: Adult; Aspartic Acid; Astrocytoma; Biopsy; Brain Neoplasms; Choline; Data Interpretation, Statistica

2011
Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    European journal of radiology, 2011, Volume: 80, Issue:2

    Topics: Area Under Curve; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Diffusion Magnetic Resonance Im

2011
Metabolism and regional cerebral blood volume in autoimmune inflammatory demyelinating lesions mimicking malignant gliomas.
    Journal of neurology, 2011, Volume: 258, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Blood Volume; Brain Neoplasms; Cerebrovas

2011
Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
    Investigative radiology, 2010, Volume: 45, Issue:12

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Biopsy; Brain Neoplasms; Choline; Contras

2010
Noninvasive evaluation of cerebral glioma grade by using multivoxel 3D proton MR spectroscopy.
    Magnetic resonance imaging, 2011, Volume: 29, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Brain Neoplasms; Choline; Creatine; Female; Glioma; H

2011
Brain F-18 Fluorocholine PET/CT for the assessment of optic pathway glioma in neurofibromatosis-1.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:10

    Topics: Brain; Choline; Glioma; Humans; Male; Neurofibromatosis 1; Optic Nerve; Positron-Emission Tomography

2010
Value of 1H-magnetic resonance spectroscopy chemical shift imaging for detection of anaplastic foci in diffusely infiltrating gliomas with non-significant contrast-enhancement.
    Journal of neurology, neurosurgery, and psychiatry, 2011, Volume: 82, Issue:5

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Female; Glioma; H

2011
Promising role of [18F] fluorocholine PET/CT vs [18F] fluorodeoxyglucose PET/CT in primary brain tumors-early experience.
    Clinical neurology and neurosurgery, 2011, Volume: 113, Issue:2

    Topics: Brain Neoplasms; Choline; Fatal Outcome; Female; Fluorine Radioisotopes; Glioblastoma; Glioma; Human

2011
Treatment of children with recurrent high grade gliomas with a bevacizumab containing regimen.
    Journal of neuro-oncology, 2011, Volume: 103, Issue:3

    Topics: Adolescent; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anti

2011
Proton magnetic resonance spectroscopic imaging in pediatric low-grade gliomas.
    Brain tumor pathology, 2010, Volume: 27, Issue:2

    Topics: Adolescent; Astrocytoma; Brain; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Diagnos

2010
Heterogeneity in malignant gliomas: a magnetic resonance analysis of spatial distribution of metabolite changes and regional blood volume.
    Journal of neuro-oncology, 2011, Volume: 103, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Cerebrovascular Circulation; Choline; Creatine; Female; Glioma; Humans

2011
pH optimization for a reliable quantification of brain tumor cell and tissue extracts with (1)H NMR: focus on choline-containing compounds and taurine.
    Analytical and bioanalytical chemistry, 2011, Volume: 399, Issue:2

    Topics: Brain; Brain Chemistry; Brain Neoplasms; Choline; Glioma; Humans; Hydrogen-Ion Concentration; Magnet

2011
Mathematical modeling of energy metabolism and hemodynamics of WHO grade II gliomas using in vivo MR data.
    Comptes rendus biologies, 2011, Volume: 334, Issue:1

    Topics: Adolescent; Adult; Aged; Algorithms; Brain Neoplasms; Cerebrovascular Circulation; Child; Choline; F

2011
Metabolic assessment of monofocal acute inflammatory demyelination using MR spectroscopy and (11)C-methionine-, (11)C-choline-, and (18)F-fluorodeoxyglucose-PET.
    Brain tumor pathology, 2011, Volume: 28, Issue:3

    Topics: Brain Neoplasms; Carbon Radioisotopes; Choline; Creatine; Demyelinating Diseases; Diagnosis, Differe

2011
Choline metabolism, proliferation, and angiogenesis in nonenhancing grades 2 and 3 astrocytoma.
    Journal of magnetic resonance imaging : JMRI, 2011, Volume: 33, Issue:4

    Topics: Adult; Astrocytoma; Biopsy; Brain Neoplasms; Cell Proliferation; Choline; Female; Glioma; Glycerylph

2011
Predicting the outcome of grade II glioma treated with temozolomide using proton magnetic resonance spectroscopy.
    British journal of cancer, 2011, Jun-07, Volume: 104, Issue:12

    Topics: Adult; Aged; Antineoplastic Agents, Alkylating; Aspartic Acid; Brain Neoplasms; Choline; Creatine; D

2011
Papillary glioneuronal tumor: unexplored entity.
    Journal of neurological surgery. Part A, Central European neurosurgery, 2012, Volume: 73, Issue:4

    Topics: Adult; Brain Neoplasms; Choline; Creatinine; Diffusion Magnetic Resonance Imaging; Female; Glioma; H

2012
Glioma residual or recurrence versus radiation necrosis: accuracy of pentavalent technetium-99m-dimercaptosuccinic acid [Tc-99m (V) DMSA] brain SPECT compared to proton magnetic resonance spectroscopy (1H-MRS): initial results.
    Journal of neuro-oncology, 2012, Volume: 106, Issue:3

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Female; Follow-Up Studie

2012
F-18 choline PET does not detect increased metabolism in F-18 fluoroethyltyrosine-negative low-grade gliomas.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:1

    Topics: Adult; Brain Neoplasms; Choline; False Negative Reactions; Female; Glioma; Humans; Male; Middle Aged

2012
Cutoff value of choline concentration reliably reveals high-grade brain tumors among other contrast-enhancing brain lesions.
    Journal of neurological surgery. Part A, Central European neurosurgery, 2012, Volume: 73, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Diseases; Brain Infarction; Brain Neoplasms; Centr

2012
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.
    Nature medicine, 2012, Jan-26, Volume: 18, Issue:4

    Topics: Algorithms; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Creatine; Female; Glioma;

2012
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.
    Nature medicine, 2012, Jan-26, Volume: 18, Issue:4

    Topics: Algorithms; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Creatine; Female; Glioma;

2012
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.
    Nature medicine, 2012, Jan-26, Volume: 18, Issue:4

    Topics: Algorithms; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Creatine; Female; Glioma;

2012
2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas.
    Nature medicine, 2012, Jan-26, Volume: 18, Issue:4

    Topics: Algorithms; Aspartic Acid; Brain; Brain Mapping; Brain Neoplasms; Choline; Creatine; Female; Glioma;

2012
Single- and multivoxel proton spectroscopy in pediatric patients with diffuse intrinsic pontine glioma.
    International journal of radiation oncology, biology, physics, 2012, Nov-01, Volume: 84, Issue:3

    Topics: Adolescent; Aspartic Acid; Brain Stem Neoplasms; Child; Child, Preschool; Choline; Creatine; Feasibi

2012
Progressive multifocal leukoencephalopathy (PML) mimicking high-grade glioma on delayed F-18 FDG PET imaging.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2012, Volume: 19, Issue:8

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Diffusion Magnetic Resonance Imaging; Fluorodeoxy

2012
The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas.
    Acta neurochirurgica, 2012, Volume: 154, Issue:8

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy, Needle; Brain Neoplasms; Choline; Female; Glioma; Hu

2012
The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas.
    Acta neurochirurgica, 2012, Volume: 154, Issue:8

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy, Needle; Brain Neoplasms; Choline; Female; Glioma; Hu

2012
The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas.
    Acta neurochirurgica, 2012, Volume: 154, Issue:8

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy, Needle; Brain Neoplasms; Choline; Female; Glioma; Hu

2012
The relationship between Cho/NAA and glioma metabolism: implementation for margin delineation of cerebral gliomas.
    Acta neurochirurgica, 2012, Volume: 154, Issue:8

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy, Needle; Brain Neoplasms; Choline; Female; Glioma; Hu

2012
Preoperative assessment using multimodal functional magnetic resonance imaging techniques in patients with brain gliomas.
    Turkish neurosurgery, 2012, Volume: 22, Issue:5

    Topics: Adolescent; Adult; Aged; Anisotropy; Aspartic Acid; Brain Neoplasms; Cerebral Cortex; Child; Choline

2012
Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
    Neurosurgery, 2002, Volume: 51, Issue:4

    Topics: Adult; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Glioma; Humans; Lactic Acid; Lip

2002
Histopathological validation of a three-dimensional magnetic resonance spectroscopy index as a predictor of tumor presence.
    Journal of neurosurgery, 2002, Volume: 97, Issue:4

    Topics: Aspartic Acid; Biopsy; Brain Neoplasms; Choline; Glioma; Humans; Magnetic Resonance Spectroscopy; Pr

2002
Metabolic response of normal and malignant tissue to acute and chronic methionine stress in athymic mice bearing human glial tumor xenografts.
    Chemical research in toxicology, 2002, Volume: 15, Issue:11

    Topics: Animals; Brain Neoplasms; Carbon-Sulfur Lyases; Choline; Choline Deficiency; Glioma; Homocysteine; H

2002
In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience.
    Radiology, 2002, Volume: 225, Issue:3

    Topics: Adult; Astrocytoma; Biopsy; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Female; Gliobl

2002
Ceramide in nitric oxide inhibition of glioma cell growth. Evidence for the involvement of ceramide traffic.
    The Journal of biological chemistry, 2003, Mar-14, Volume: 278, Issue:11

    Topics: Adenosine Triphosphate; Animals; Biological Transport; Brefeldin A; Cell Division; Cell Line; Cerami

2003
Combination of single-voxel proton MR spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumors.
    AJNR. American journal of neuroradiology, 2003, Volume: 24, Issue:2

    Topics: Adolescent; Adult; Aged; Alanine; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creat

2003
[Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors].
    Annales de medecine interne, 2002, Volume: 153, Issue:8

    Topics: Aspartic Acid; Biomarkers; Brain Abscess; Brain Neoplasms; Choline; Computer Graphics; Creatine; Dia

2002
[Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds].
    No shinkei geka. Neurological surgery, 2003, Volume: 31, Issue:2

    Topics: Adult; Aged; Biomarkers; Brain Neoplasms; Choline; Female; Glioma; Humans; Magnetic Resonance Spectr

2003
Differentiating primary central nervous system lymphoma from glioma in humans using localised proton magnetic resonance spectroscopy.
    Neuroscience letters, 2003, May-22, Volume: 342, Issue:3

    Topics: Central Nervous System Neoplasms; Choline; Diagnosis, Differential; Glioma; Humans; Immunocompetence

2003
Preoperative proton-MR spectroscopy of gliomas--correlation with quantitative nuclear morphology in surgical specimen.
    Journal of neuro-oncology, 2003, Volume: 63, Issue:3

    Topics: Brain Neoplasms; Cell Division; Cell Nucleus; Choline; Fourier Analysis; Glioma; Humans; Immunoenzym

2003
Metabolite changes in BT4C rat gliomas undergoing ganciclovir-thymidine kinase gene therapy-induced programmed cell death as studied by 1H NMR spectroscopy in vivo, ex vivo, and in vitro.
    The Journal of biological chemistry, 2003, Nov-14, Volume: 278, Issue:46

    Topics: Animals; Apoptosis; Brain; Brain Neoplasms; Cell Line, Tumor; Choline; Diffusion; Ganciclovir; Genet

2003
Use of 18F-choline and 11C-choline as contrast agents in positron emission tomography imaging-guided stereotactic biopsy sampling of gliomas.
    Journal of neurosurgery, 2003, Volume: 99, Issue:3

    Topics: Adolescent; Adult; Aged; Biopsy; Brain Neoplasms; Choline; Contrast Media; Female; Glioma; Humans; M

2003
A chemometric approach for brain tumor classification using magnetic resonance imaging and spectroscopy.
    Analytical chemistry, 2003, Oct-15, Volume: 75, Issue:20

    Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Neoplasms; Cerebrospinal Fluid; Choline; Creatine; Disc

2003
Extracellular levels of amino acids and choline in human high grade gliomas: an intraoperative microdialysis study.
    Neurochemical research, 2004, Volume: 29, Issue:1

    Topics: Adult; Aged; Amino Acids; Brain Neoplasms; Cell Division; Choline; Extracellular Space; Female; Glio

2004
1H-MRSI of radiation effects in normal-appearing white matter: dose-dependence and impact on automated spectral classification.
    Journal of magnetic resonance imaging : JMRI, 2004, Volume: 19, Issue:4

    Topics: Aspartic Acid; Brain; Brain Chemistry; Brain Neoplasms; Choline; Creatine; Dose-Response Relationshi

2004
[Usefulness of Cho/Cr ratio in proton MR spectroscopy for differentiating residual/recurrent glioma from non-neoplastic lesions].
    Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica, 2004, Volume: 64, Issue:3

    Topics: Adolescent; Adult; Aged; Brain Neoplasms; Child; Child, Preschool; Choline; Creatine; Female; Glioma

2004
In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
    Magnetic resonance imaging, 2004, Volume: 22, Issue:5

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Cerebellar Neoplasms; C

2004
Proton magnetic resonance spectroscopy-guided biopsy for cerebral glial tumors.
    Journal of the Formosan Medical Association = Taiwan yi zhi, 2004, Volume: 103, Issue:6

    Topics: Adult; Aged; Biopsy; Brain Neoplasms; Choline; Creatine; Female; Glioma; Humans; Ki-67 Antigen; Magn

2004
In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
    Magnetic resonance imaging, 2004, Volume: 22, Issue:7

    Topics: Adult; Aged; Aspartic Acid; Body Water; Brain; Brain Neoplasms; Child; Child, Preschool; Choline; Cr

2004
Perfusion magnetic resonance imaging and magnetic resonance spectroscopy of cerebral gliomas showing imperceptible contrast enhancement on conventional magnetic resonance imaging.
    Australasian radiology, 2004, Volume: 48, Issue:3

    Topics: Adult; Blood Volume; Brain; Choline; Creatine; Female; Glioma; Humans; Magnetic Resonance Angiograph

2004
Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    NeuroImage, 2004, Volume: 23, Issue:2

    Topics: Adult; Algorithms; Aspartic Acid; Astrocytoma; Automation; Biopsy; Brain Chemistry; Brain Mapping; B

2004
Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
    Academic radiology, 2005, Volume: 12, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Choline; Creatin

2005
Clinicopathological examination of glioma by proton magnetic resonance spectroscopy background.
    Brain tumor pathology, 2004, Volume: 21, Issue:1

    Topics: Adult; Aspartic Acid; Brain Neoplasms; Choline; Female; Glioma; Humans; Lactic Acid; Magnetic Resona

2004
Multimodal metabolic imaging of cerebral gliomas: positron emission tomography with [18F]fluoroethyl-L-tyrosine and magnetic resonance spectroscopy.
    Journal of neurosurgery, 2005, Volume: 102, Issue:2

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy; Brain; Brain Neoplasms; Child; Child, Preschool; Cho

2005
Spectroscopy and navigation.
    Journal of neurosurgery, 2005, Volume: 102, Issue:2

    Topics: Algorithms; Aspartic Acid; Brain; Brain Neoplasms; Choline; Glioma; Humans; Image Processing, Comput

2005
Proton magnetic resonance spectroscopic imaging integrated into image-guided surgery: correlation to standard magnetic resonance imaging and tumor cell density.
    Neurosurgery, 2005, Volume: 56, Issue:2 Suppl

    Topics: Algorithms; Aspartic Acid; Biopsy; Brain Neoplasms; Cell Count; Choline; Feasibility Studies; Glioma

2005
Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    International journal of radiation oncology, biology, physics, 2005, May-01, Volume: 62, Issue:1

    Topics: Aspartic Acid; Brain Stem Neoplasms; Child; Child, Preschool; Choline; Creatine; Disease Progression

2005
High-resolution magic-angle-spinning 1H NMR spectroscopy reveals different responses in choline-containing metabolites upon gene therapy-induced programmed cell death in rat brain glioma.
    NMR in biomedicine, 2005, Volume: 18, Issue:4

    Topics: Animals; Apoptosis; Biomarkers; Brain Neoplasms; Choline; Female; Genetic Therapy; Glioma; Image Int

2005
Correlation between choline and MIB-1 index in human gliomas. A quantitative in proton MR spectroscopy study.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2005, Volume: 12, Issue:4

    Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Glioma; Humans; Ki-67 Antigen; Magnetic Resonance Spe

2005
The contribution of magnetic resonance spectroscopy and echoplanar perfusion-weighted MRI in the initial assessment of brain tumours.
    Journal of neuro-oncology, 2005, Volume: 72, Issue:3

    Topics: Adolescent; Adult; Aged; Astrocytoma; Blood Volume; Brain Neoplasms; Child; Child, Preschool; Cholin

2005
Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
    Chinese medical journal, 2005, Aug-05, Volume: 118, Issue:15

    Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Glioma; Glycine; Humans; Inositol; Magnetic

2005
Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemotherapy.
    Journal of neuro-oncology, 2006, Volume: 76, Issue:2

    Topics: Adult; Antineoplastic Agents; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Disease-Free Surviv

2006
Independent component analysis to proton spectroscopic imaging data of human brain tumours.
    European journal of radiology, 2005, Volume: 56, Issue:2

    Topics: Algorithms; Aspartic Acid; Astrocytoma; Brain Neoplasms; Cell Proliferation; Choline; Creatine; Glio

2005
In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
    General physiology and biophysics, 2005, Volume: 24, Issue:3

    Topics: Aspartic Acid; Astrocytes; Astrocytoma; Brain; Brain Neoplasms; Choline; Chromium; Creatine; Gliobla

2005
Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Radiology, 2006, Volume: 238, Issue:3

    Topics: Adolescent; Adult; Aspartic Acid; Brain Neoplasms; Case-Control Studies; Choline; Creatine; Female;

2006
Uptake of 18F-fluorocholine, 18F-fluoro-ethyl-L: -tyrosine and 18F-fluoro-2-deoxyglucose in F98 gliomas in the rat.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:6

    Topics: Animals; Blood-Brain Barrier; Brain Injuries; Brain Neoplasms; Cell Line, Tumor; Choline; Fluorodeox

2006
Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy.
    Neuroradiology, 2006, Volume: 48, Issue:9

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Contrast Media; Creatine; Diffusio

2006
3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
    AJNR. American journal of neuroradiology, 2006, Volume: 27, Issue:7

    Topics: Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Echo-Planar Imaging; Female; Glioma;

2006
Disarrangement of fiber tracts and decline of neuronal density correlate in glioma patients--a combined diffusion tensor imaging and 1H-MR spectroscopy study.
    AJNR. American journal of neuroradiology, 2006, Volume: 27, Issue:7

    Topics: Adult; Aged; Anisotropy; Aspartic Acid; Astrocytoma; Brain; Brain Neoplasms; Cell Size; Choline; Cre

2006
Long-term normal-appearing brain tissue monitoring after irradiation using proton magnetic resonance spectroscopy in vivo: statistical analysis of a large group of patients.
    International journal of radiation oncology, biology, physics, 2006, Nov-01, Volume: 66, Issue:3

    Topics: Adult; Aged; Aspartic Acid; Blood-Brain Barrier; Brain; Brain Neoplasms; Choline; Creatine; Female;

2006
Comments and controversies: magnetic resonance spectroscopy and gliomas.
    Cancer imaging : the official publication of the International Cancer Imaging Society, 2006, Sep-07, Volume: 6

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Glioma; Humans; Magnetic Resonance Spectroscopy;

2006
Proton magnetic resonance spectroscopy in childhood brainstem lesions.
    Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2007, Volume: 23, Issue:3

    Topics: Adolescent; Amino Acids; Aspartic Acid; Brain Chemistry; Brain Diseases; Brain Stem; Brain Stem Neop

2007
Use of MR spectroscopy and functional imaging in the treatment planning of gliomas.
    The British journal of radiology, 2007, Volume: 80, Issue:953

    Topics: Brain; Brain Neoplasms; Choline; Cranial Irradiation; Creatine; Glioma; Humans; Image Processing, Co

2007
Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
    International journal of radiation oncology, biology, physics, 2007, May-01, Volume: 68, Issue:1

    Topics: Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Diffusion Magn

2007
Proton magnetic resonance spectroscopic imaging in the border zone of gliomas: correlation of metabolic and histological changes at low tumor infiltration--initial results.
    Investigative radiology, 2007, Volume: 42, Issue:4

    Topics: Aspartic Acid; Choline; Creatine; Glioma; Humans; Magnetic Resonance Spectroscopy; Neoplasm Invasive

2007
Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
    Diagnostic and interventional radiology (Ankara, Turkey), 2007, Volume: 13, Issue:1

    Topics: Adult; Aged; Brain Neoplasms; Choline; Creatine; Female; Glioma; Humans; Magnetic Resonance Imaging;

2007
Uptake of 18F-Fluorocholine, 18F-FET, and 18F-FDG in C6 gliomas and correlation with 131I-SIP(L19), a marker of angiogenesis.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2007, Volume: 48, Issue:4

    Topics: Animals; Antibodies; Brain Neoplasms; Cell Line, Tumor; Choline; Fibronectins; Glioma; Male; Neovasc

2007
Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
    Neuroradiology, 2007, Volume: 49, Issue:10

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Biopsy; Blood Flow Velocity; Brain; Brain Neoplasms; Choline

2007
Dysembryoplastic neuroepithelial tumors: proton MR spectroscopy, diffusion and perfusion characteristics.
    Neuroradiology, 2007, Volume: 49, Issue:10

    Topics: Adolescent; Adult; Blood Flow Velocity; Choline; Creatine; Diagnosis, Differential; Diffusion Magnet

2007
Monovoxel 1H magnetic resonance spectroscopy in the progression of gliomas.
    European neurology, 2007, Volume: 58, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Disease Progression; Female; Glioma;

2007
Diffusion tensor imaging and chemical shift imaging assessment of heterogeneity in low grade glioma under temozolomide chemotherapy.
    Cancer investigation, 2007, Volume: 25, Issue:8

    Topics: Antineoplastic Agents, Alkylating; Brain Neoplasms; Choline; Dacarbazine; Diffusion Magnetic Resonan

2007
Biodisposition and metabolism of [(18)F]fluorocholine in 9L glioma cells and 9L glioma-bearing fisher rats.
    European journal of nuclear medicine and molecular imaging, 2008, Volume: 35, Issue:6

    Topics: Animals; Cell Line, Tumor; Choline; Glioma; Male; Metabolic Clearance Rate; Organ Specificity; Radio

2008
Relationship between choline and apparent diffusion coefficient in patients with gliomas.
    Journal of magnetic resonance imaging : JMRI, 2008, Volume: 27, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Brain; Brain Chemistry; Brain Neoplasms; Choline; Diffusion Magnetic

2008
Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography.
    AJNR. American journal of neuroradiology, 2008, Volume: 29, Issue:6

    Topics: Adult; Brain Neoplasms; Carbon Radioisotopes; Choline; Female; Fluorodeoxyglucose F18; Gene Expressi

2008
A diffusible factor responsible for the determination of cholinergic functions in cultured sympathetic neurons. Partial purification and characterization.
    The Journal of biological chemistry, 1981, Apr-10, Volume: 256, Issue:7

    Topics: Animals; Animals, Newborn; Cell Line; Cells, Cultured; Choline; Ganglia, Sympathetic; Glioma; Kineti

1981
Choline uptake by the neuroblastoma x glioma hybrid, NG108-15.
    Journal of neurochemistry, 1980, Volume: 35, Issue:4

    Topics: Animals; Biological Transport; Bucladesine; Cell Line; Choline; Clone Cells; Glioma; Hemicholinium 3

1980
Uptake and release of choline in cultures of human glioma cells.
    Cellular and molecular neurobiology, 1981, Volume: 1, Issue:4

    Topics: Cell Line; Choline; Glioma; Humans; Tumor Cells, Cultured

1981
Comparison of lipids and lipid metabolism in a human glioma cell line, its clone, and oligodendroglia.
    Cancer research, 1983, Volume: 43, Issue:3

    Topics: Acetates; Acetic Acid; Cell Line; Choline; Chromatography, Thin Layer; Clone Cells; Glioma; Glycolip

1983
A new capillary tube system for measuring the uptake and release of materials from cultured cells.
    Analytical biochemistry, 1980, Jan-15, Volume: 101, Issue:2

    Topics: Acetylcholine; Animals; Biological Transport; Cell Line; Choline; Glioma; Hybrid Cells; Kinetics; Me

1980
In vivo proton MR spectroscopy of human gliomas: definition of metabolic coordinates for multi-dimensional classification.
    Magnetic resonance in medicine, 1995, Volume: 34, Issue:2

    Topics: Adult; Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Cluster Analysis; Creatine; Discriminan

1995
Characterization of intracranial mass lesions with in vivo proton MR spectroscopy.
    AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:8

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Diseases; Brain Neoplasms; Child; Choline; Crea

1995
Spectral editing with adiabatic pulses.
    Journal of magnetic resonance. Series B, 1995, Volume: 109, Issue:2

    Topics: Animals; Aspartic Acid; Brain Neoplasms; Carbon Isotopes; Choline; Creatine; Feasibility Studies; Gl

1995
Proton magnetic resonance spectroscopy of astrocytic tumors: an in vitro study.
    Neurologia medico-chirurgica, 1993, Volume: 33, Issue:6

    Topics: Antibodies, Monoclonal; Astrocytoma; Brain Neoplasms; Choline; Creatine; Diagnosis, Differential; Fe

1993
Non-invasive characterization of brain tumor by in-vivo proton magnetic resonance spectroscopy.
    Japanese journal of cancer research : Gann, 1995, Volume: 86, Issue:3

    Topics: Aspartic Acid; Astrocytoma; Brain Neoplasms; Choline; Creatine; Ependymoma; Glioma; Humans; Magnetic

1995
Proton MR spectroscopy in patients with neurofibromatosis type 1: evaluation of hamartomas and clinical correlation.
    AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:1

    Topics: Adolescent; Adult; Aspartic Acid; Astrocytoma; Brain; Brain Diseases; Brain Neoplasms; Cerebellar Di

1995
Effects of therapy on the 1H NMR spectrum of a human glioma line.
    Magnetic resonance imaging, 1994, Volume: 12, Issue:6

    Topics: Animals; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Glioma; Lactates; Magnetic Resonance Spe

1994
Proton MR spectroscopy of experimental brain tumors in vivo.
    Acta neurochirurgica. Supplementum, 1994, Volume: 60

    Topics: Animals; Aspartic Acid; Blood Glucose; Brain Edema; Brain Neoplasms; Caudate Nucleus; Cell Line; Cho

1994
In vitro and in vivo 13C and 31P NMR analyses of phosphocholine metabolism in rat glioma cells.
    Magnetic resonance in medicine, 1994, Volume: 32, Issue:3

    Topics: Animals; Carbon Isotopes; Cell Division; Choline; Ethanolamines; Glioma; Magnetic Resonance Spectros

1994
Localized proton spectroscopy of inoperable brain gliomas. Response to radiation therapy.
    Journal of neuro-oncology, 1993, Volume: 17, Issue:1

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Glioma; Humans; Lactates; Lactic Acid; Magnetic Resonance I

1993
Quantitative proton spectroscopy and histology of a canine brain tumor model.
    Magnetic resonance in medicine, 1993, Volume: 30, Issue:4

    Topics: Animals; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Dogs; Glioma; Lactates; Lactic Acid; Mag

1993
In vivo, ex vivo, and in vitro one- and two-dimensional nuclear magnetic resonance spectroscopy of an intracerebral glioma in rat brain: assignment of resonances.
    Journal of neurochemistry, 1994, Volume: 62, Issue:1

    Topics: Amino Acids; Animals; Brain; Brain Neoplasms; Choline; Fatty Acids, Nonesterified; Glioma; Lactates;

1994
[1H magnetic resonance spectroscopy in intracranial tumors and cerebral ischemia].
    Der Radiologe, 1993, Volume: 33, Issue:11

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Ischemia; Child; Child, Preschool;

1993
Limited metabolic interaction of serine with ethanolamine and choline in the turnover of phosphatidylserine, phosphatidylethanolamine and plasmalogens in cultured glioma cells.
    Biochimica et biophysica acta, 1993, Jun-12, Volume: 1168, Issue:2

    Topics: Animals; Carbon Radioisotopes; Choline; Dose-Response Relationship, Drug; Ethanolamine; Ethanolamine

1993
Noninvasive evaluation of malignancy of brain tumors with proton MR spectroscopy.
    AJNR. American journal of neuroradiology, 1996, Volume: 17, Issue:4

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Energy Metabolism; Femal

1996
Phorbol ester stimulation of phosphatidylcholine synthesis in four cultured neural cell lines: correlations with expression of protein kinase C isoforms.
    Neurochemical research, 1995, Volume: 20, Issue:12

    Topics: Animals; Blotting, Northern; Blotting, Western; Choline; Gene Expression; Glioma; Humans; Isoenzymes

1995
Proton magnetic resonance spectroscopy and intracranial tumours: clinical perspectives.
    Journal of neurology, 1996, Volume: 243, Issue:10

    Topics: Adenoma; Aspartic Acid; Brain Neoplasms; Choline; Craniopharyngioma; Creatinine; Glioma; Humans; Lym

1996
Brain tumors: detection with C-11 choline PET.
    Radiology, 1997, Volume: 202, Issue:2

    Topics: Adult; Aged; Animals; Brain Neoplasms; Child; Choline; Female; Glioma; Humans; Male; Middle Aged; Ox

1997
Ethanol potentiates the uptake of [14C]serine into phosphatidylserine by base-exchange reaction in NG 108-15 cells.
    Neurochemical research, 1996, Volume: 21, Issue:3

    Topics: Animals; Carbon Radioisotopes; Choline; Ethanol; Ethanolamine; Ethanolamines; Glioma; Hybrid Cells;

1996
Absolute concentrations of metabolites in human brain tumors using in vitro proton magnetic resonance spectroscopy.
    NMR in biomedicine, 1997, Volume: 10, Issue:1

    Topics: Adenoma; Adolescent; Adult; Aged; Amino Acids; Brain; Brain Neoplasms; Child; Choline; Creatine; Fem

1997
Evaluation of metabolic heterogeneity in brain tumors using 1H-chemical shift imaging method.
    NMR in biomedicine, 1997, Volume: 10, Issue:1

    Topics: Aspartic Acid; Brain Neoplasms; Choline; Creatine; Evaluation Studies as Topic; Glioma; Humans; Imag

1997
Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study.
    Journal of neurosurgery, 1997, Volume: 87, Issue:4

    Topics: Adult; Aged; Aspartic Acid; Biomarkers, Tumor; Biopsy; Brain Neoplasms; Cell Transformation, Neoplas

1997
Proton (1H) MR spectroscopy for routine diagnostic evaluation of brain lesions.
    Acta radiologica (Stockholm, Sweden : 1987), 1997, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain Diseases; Brain Neo

1997
Ro31-8220 inhibits protein kinase C to block the phorbol ester-stimulated release of choline- and ethanolamine-metabolites from C6 glioma cells: p70 S6 kinase and MAPKAP kinase-1beta do not function downstream of PKC in activating PLD.
    FEBS letters, 1997, Nov-03, Volume: 417, Issue:1

    Topics: Androstadienes; Animals; Choline; Enzyme Inhibitors; Ethanolamine; Flavonoids; Glioma; Indoles; Phos

1997
Magnetic resonance spectroscopy guided brain tumor resection: differentiation between recurrent glioma and radiation change in two diagnostically difficult cases.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 1998, Volume: 25, Issue:1

    Topics: Adult; Brain; Brain Neoplasms; Choline; Combined Modality Therapy; Diagnosis, Differential; Glioma;

1998
1H MR spectroscopy monitoring of changes in choline peak area and line shape after Gd-contrast administration.
    Magnetic resonance imaging, 1998, Volume: 16, Issue:10

    Topics: Adult; Aged; Brain; Brain Neoplasms; Choline; Contrast Media; Female; Gadolinium DTPA; Glioma; Human

1998
Characterization of choline compounds with in vitro 1H magnetic resonance spectroscopy for the discrimination of primary brain tumors.
    Investigative radiology, 1999, Volume: 34, Issue:3

    Topics: Adult; Aged; Brain Neoplasms; Choline; Female; Glioma; Humans; In Vitro Techniques; Magnetic Resonan

1999
Ca2+-activated K channel of the BK-type in the inner mitochondrial membrane of a human glioma cell line.
    Biochemical and biophysical research communications, 1999, Apr-13, Volume: 257, Issue:2

    Topics: Calcium; Charybdotoxin; Choline; Dose-Response Relationship, Drug; Glioma; Gluconates; Humans; Intra

1999
Variation of post-treatment H-MRSI choline intensity in pediatric gliomas.
    Journal of neuro-oncology, 1999, Volume: 41, Issue:3

    Topics: Astrocytoma; Biopsy; Brain Neoplasms; Child; Child, Preschool; Choline; Follow-Up Studies; Glioma; H

1999
Comparison of relative cerebral blood volume and proton spectroscopy in patients with treated gliomas.
    AJNR. American journal of neuroradiology, 2000, Volume: 21, Issue:2

    Topics: Adult; Aspartic Acid; Blood Volume; Brain; Brain Neoplasms; Choline; Combined Modality Therapy; Fema

2000
Correlation between choline level measured by proton MR spectroscopy and Ki-67 labeling index in gliomas.
    AJNR. American journal of neuroradiology, 2000, Volume: 21, Issue:4

    Topics: Adult; Aged; Brain Neoplasms; Cell Division; Choline; Female; Glioma; Humans; Ki-67 Antigen; Magneti

2000
Quantitative proton magnetic resonance spectroscopy of focal brain lesions.
    Pediatric neurology, 2000, Volume: 23, Issue:1

    Topics: Adolescent; Aspartic Acid; Biomarkers, Tumor; Brain; Brain Abscess; Brain Diseases; Brain Neoplasms;

2000
An automated technique for the quantitative assessment of 3D-MRSI data from patients with glioma.
    Journal of magnetic resonance imaging : JMRI, 2001, Volume: 13, Issue:2

    Topics: Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Female; Glioma; Humans; Imaging, Three-Dimens

2001
Serial proton MR spectroscopic imaging of recurrent malignant gliomas after gamma knife radiosurgery.
    AJNR. American journal of neuroradiology, 2001, Volume: 22, Issue:4

    Topics: Adult; Aspartic Acid; Brain; Brain Neoplasms; Choline; Energy Metabolism; Female; Follow-Up Studies;

2001
High glycolytic activity in rat glioma demonstrated in vivo by correlation peak 1H magnetic resonance imaging.
    Cancer research, 2001, Jul-15, Volume: 61, Issue:14

    Topics: Alanine; Animals; Aspartic Acid; Brain Neoplasms; Choline; Creatine; Ethanolamines; Female; Glioma;

2001
Mapping extracellular pH in rat brain gliomas in vivo by 1H magnetic resonance spectroscopic imaging: comparison with maps of metabolites.
    Cancer research, 2001, Sep-01, Volume: 61, Issue:17

    Topics: Animals; Aspartic Acid; Brain Neoplasms; Buffers; Choline; Contrast Media; Creatine; Extracellular S

2001
Correlation between magnetic resonance spectroscopy imaging and image-guided biopsies: semiquantitative and qualitative histopathological analyses of patients with untreated glioma.
    Neurosurgery, 2001, Volume: 49, Issue:4

    Topics: Adolescent; Adult; Aged; Aspartic Acid; Brain; Brain Neoplasms; Choline; Creatine; Dominance, Cerebr

2001
[Brain tumors: interest of magnetic resonance spectroscopy for the diagnosis and the prognosis].
    Revue neurologique, 2001, Volume: 157, Issue:8-9 Pt 1

    Topics: Aspartic Acid; Biopsy; Brain; Brain Neoplasms; Choline; Diagnosis, Differential; Energy Metabolism;

2001
[1H-MR Spectroscopy of brain tumors in the course of radiation therapy: Use of fast spectroscopic imaging and single-voxel spectroscopy for diagnosing recurrence].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 2002, Volume: 174, Issue:1

    Topics: Adult; Aged; Brain; Brain Neoplasms; Choline; Combined Modality Therapy; Cranial Irradiation; Energy

2002
Proton magnetic resonance spectroscopy of cerebral glioma after irradiation.
    Chang Gung medical journal, 2001, Volume: 24, Issue:11

    Topics: Brain; Brain Neoplasms; Choline; Creatine; Glioma; Humans; Magnetic Resonance Spectroscopy

2001
High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
    Radiology, 2002, Volume: 222, Issue:3

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspartic Acid; Blood Volume; Brain; Brain Chemistry; Bra

2002
The effect of Gd-DTPA on T(1)-weighted choline signal in human brain tumours.
    Magnetic resonance imaging, 2002, Volume: 20, Issue:1

    Topics: Brain Neoplasms; Choline; Contrast Media; Gadolinium DTPA; Glioma; Humans; Magnetic Resonance Spectr

2002
Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
    Neuroradiology, 2002, Volume: 44, Issue:5

    Topics: Aspartic Acid; Brain Abscess; Brain Neoplasms; Cerebral Infarction; Choline; Creatine; Diagnosis, Di

2002
Counter transport of glutamine and choline in cultures of human glioma cells.
    Biochemical and biophysical research communications, 1979, Jun-27, Volume: 88, Issue:4

    Topics: Biological Transport; Cells, Cultured; Choline; Diffusion; Glioma; Glutamine; Humans; Kinetics; Neop

1979
Calcium fluxes in cultured and bulk isolated neuronal and glial cells.
    Journal of neurochemistry, 1977, Volume: 29, Issue:3

    Topics: Acetylcholine; Animals; Astrocytes; Brain Neoplasms; Calcium; Cells, Cultured; Choline; Glioma; Huma

1977
On the uptake mechanism of choline in nerve cell cultures.
    Advances in experimental medicine and biology, 1976, Volume: 69

    Topics: Animals; Astrocytes; Brain; Chick Embryo; Choline; Cholinesterase Inhibitors; Clone Cells; Cyanides;

1976
Synapse formation between clonal neuroblastoma X glioma hybrid cells and striated muscle cells.
    Proceedings of the National Academy of Sciences of the United States of America, 1976, Volume: 73, Issue:1

    Topics: Action Potentials; Calcium; Cells, Cultured; Choline; Glioma; Hybrid Cells; Membrane Potentials; Mus

1976
Activation of phospholipase D by platelet-derived growth factor (PDGF) in rat C6 glioma cells: possible role in mitogenic signal transduction.
    Neurological research, 1992, Volume: 14, Issue:5

    Topics: Animals; Choline; DNA Replication; DNA, Neoplasm; Enzyme Activation; Glioma; Glycerophospholipids; K

1992
Proton magnetic resonance spectroscopic imaging for metabolic characterization of demyelinating plaques.
    Annals of neurology, 1992, Volume: 31, Issue:3

    Topics: Acute Disease; Adult; Aspartic Acid; Biopsy; Brain Chemistry; Brain Neoplasms; Choline; Creatine; De

1992
Characterization of palytoxin-induced channels in mouse neuroblastoma cells.
    Toxicon : official journal of the International Society on Toxinology, 1990, Volume: 28, Issue:10

    Topics: Acrylamides; Animals; Calcium; Cell Membrane Permeability; Choline; Cnidarian Venoms; Electric Condu

1990
Effects of insulin on glucose uptake in cultured cells from the central nervous system of rodent.
    The International journal of biochemistry, 1991, Volume: 23, Issue:9

    Topics: Animals; Calcium; Carbachol; Central Nervous System; Choline; Deoxyglucose; Glioma; Insulin; Kinetic

1991
Inhibition of phosphatidylcholine and phosphatidylethanolamine biosynthesis by cytochalasin B in cultured glioma cells: potential regulation of biosynthesis by Ca(2+)-dependent mechanisms.
    Biochimica et biophysica acta, 1991, Jul-09, Volume: 1084, Issue:2

    Topics: Animals; Biological Transport, Active; Calcium; Carbon Radioisotopes; Cell Line; Choline; Cytochalas

1991
Channeling of intermediates in the CDP-choline pathway of phosphatidylcholine biosynthesis in cultured glioma cells is dependent on intracellular Ca2+.
    The Journal of biological chemistry, 1991, Jul-05, Volume: 266, Issue:19

    Topics: Animals; Calcium; Choline; Cytidine Diphosphate Choline; Electricity; Glioma; Permeability; Phosphat

1991
Organic cations substituted for sodium are toxic to cultured rat glioma cells.
    Molecular and cellular biochemistry, 1990, Jan-18, Volume: 92, Issue:1

    Topics: Animals; Cations; Choline; Glioma; Osmolar Concentration; Rats; Sodium; Tumor Cells, Cultured

1990
Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors.
    Radiology, 1989, Volume: 172, Issue:2

    Topics: Adult; Aspartic Acid; Brain Chemistry; Brain Diseases; Brain Neoplasms; Choline; Creatinine; Cysts;

1989
Alterations of phospholipid metabolism by phorbol esters and fatty acids occur by different intracellular mechanisms in cultured glioma, neuroblastoma, and hybrid cells.
    The Journal of biological chemistry, 1989, Feb-15, Volume: 264, Issue:5

    Topics: Animals; Cell Line; Choline; Ethanolamine; Ethanolamines; Fatty Acids; Glioma; Hybrid Cells; Kinetic

1989
Isolation of plasma membranes from cultured glioma cells and application to evaluation of membrane sphingomyelin turnover.
    Analytical biochemistry, 1988, Nov-01, Volume: 174, Issue:2

    Topics: Biomarkers; Cell Membrane; Cells, Cultured; Centrifugation, Density Gradient; Choline; Enzymes; Glio

1988
Differential regulation of phosphatidylcholine biosynthesis by 12-O-tetradecanoylphorbol-13-acetate and diacylglycerol in NG108-15 neuroblastoma x glioma hybrid cells.
    The Journal of biological chemistry, 1987, Dec-25, Volume: 262, Issue:36

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Choline; Chromatography, High Pressure Liqui

1987
Phosphatidylcholine biosynthesis in the neuroblastoma-glioma hybrid cell line NG108-15: stimulation by phorbol esters.
    Journal of neurochemistry, 1986, Volume: 47, Issue:6

    Topics: Animals; Cell Line; Choline; Ethanolamine; Ethanolamines; Glioma; Inositol; Neuroblastoma; Phorbol E

1986
AF64A: an active site directed irreversible inhibitor of choline acetyltransferase.
    Journal of neurochemistry, 1985, Volume: 44, Issue:2

    Topics: Animals; Aziridines; Azirines; Cell Line; Choline; Choline Kinase; Choline O-Acetyltransferase; Chol

1985
Cholinergic differentiation of clonal rat pheochromocytoma cells (PC12) induced by factors contained in glioma-conditioned medium: enhancement of high-affinity choline uptake system and reduction of norepinephrine uptake system.
    Brain research, 1986, Volume: 389, Issue:1-2

    Topics: Acetylcholine; Adrenal Gland Neoplasms; Animals; Cell Differentiation; Choline; Cholinergic Fibers;

1986
Cultured cell systems and methods for neurobiology.
    Methods in enzymology, 1974, Volume: 32

    Topics: Acetylcholine; Acetylcholinesterase; Acetyltransferases; Animals; Brain; Brain Neoplasms; Carbon Rad

1974
The influence of non-neuronal cells on catecholamine and acetylcholine synthesis and accumulation in cultures of dissociated sympathetic neurons.
    Proceedings of the National Academy of Sciences of the United States of America, 1974, Volume: 71, Issue:9

    Topics: Acetylcholine; Animals; Catecholamines; Cells, Cultured; Choline; Cytarabine; Fibroblasts; Floxuridi

1974
High activity of choline acetyltransferase induced in neuroblastoma x glia hybrid cells.
    Experimental cell research, 1974, Volume: 85, Issue:2

    Topics: Acetylcholinesterase; Acetyltransferases; Animals; Cell Fusion; Cell Line; Choline; Chromosomes; Clo

1974